10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the quarterly period ended June 30, 2023

☐         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from                        to

Commission File No. 0-18492

DLH HOLDINGS CORP.

(Exact name of registrant as specified in its charter)

New Jersey			22-1899798
(State or other jurisdiction of  incorporation or organization)			(I.R.S. Employer Identification No.)
3565 Piedmont Road,	Building 3,	Suite 700	30305
Atlanta,	Georgia		(Zip code)
(Address of principal executive offices)

(770) 554-3545

(Registrant’s telephone number, including area code)

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	DLHC	Nasdaq	Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒     No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒   No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller Reporting Company	☒
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 13,899,969 shares of Common Stock, par value $0.001 per share, were outstanding as of July 31, 2023.

DLH HOLDINGS CORP.

FORM 10-Q

Table of Contents

	Page No.
Part I — Financial Information	3
Item 1. Financial Statements	3
Consolidated Statements of Operations for the three and nine months ended June 30, 2023 and 2022 (Unaudited)	3
Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and September 30, 2022	4
Consolidated Statements of Cash Flows for the nine months ended June 30, 2023 and 2022 (Unaudited)	5
Consolidated Statements of Shareholders' Equity for the three and nine months ended June 30, 2023 and 2022 (Unaudited)	6
Notes to Consolidated Financial Statements (Unaudited)	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3. Quantitative and Qualitative Disclosures about Market Risk	34
Item 4. Controls and Procedures	35
Part II — Other Information	35
Item 1. Legal Proceedings	35
Item 1A. Risk Factors	36
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	36
Item 3. Defaults Upon Senior Securities	36
Item 4. Mine Safety Disclosures	36
Item 5. Other Information	36
Item 6. Exhibits	37
Signatures	38

2

PART I — FINANCIAL INFORMATION

ITEM I: FINANCIAL STATEMENTS

DLH HOLDINGS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

	(unaudited)				(unaudited)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Revenue	$	102,241	$	66,440	$	274,385	$	327,940
Cost of operations:
Contract costs	80,919		49,668		216,779		271,184
General and administrative costs	9,935		7,535		27,670		22,178
Corporate development costs	—		250		1,735		250
Depreciation and amortization	4,280		1,873		11,281		5,740
Total operating costs	95,134		59,326		257,465		299,352
Income from operations	7,107		7,114		16,920		28,588
Interest expense	4,917		512		11,512		1,739
Income before provision for income taxes	2,190		6,602		5,408		26,849
Income tax expense	452		1,738		1,318		7,003
Net income	$	1,738	$	4,864	$	4,090	$	19,846
Net income per share - basic	$	0.13	$	0.38	$	0.30	$	1.55
Net income per share - diluted	$	0.12	$	0.34	$	0.28	$	1.40
Weighted average common stock outstanding
Basic	13,854		12,812		13,638		12,779
Diluted	14,539		14,235		14,421		14,205

The accompanying notes are an integral part of these consolidated financial statements.

3

DLH HOLDINGS CORP.

CONSOLIDATED BALANCE SHEETS

(In thousands, except par value of shares) 

	June 30, 2023		September 30, 2022
	(unaudited)
ASSETS
Current assets:
Cash	$	530	$	228
Accounts receivable	67,882		40,496
Other current assets	4,082		2,878
Total current assets	72,494		43,602
Equipment and improvements, net	1,690		1,704
Operating lease right-of-use assets	17,911		16,851
Goodwill	138,301		65,643
Intangible assets, net	128,891		40,884
Other long-term assets	88		328
Total assets	$	359,375	$	169,012
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Operating lease liabilities - current	$	3,478	$	2,235
Accrued payroll	17,545		9,444
Debt obligations - current, net of deferred financing costs	28,716		—
Accounts payable and accrued liabilities	25,602		26,862
Total current liabilities	75,341		38,541
Long-term liabilities:
Deferred taxes, net	1,203		1,534
Operating lease liabilities - long-term	16,485		16,461
Debt obligations - long-term, net of deferred financing costs	159,379		20,416
Other long-term liabilities	1,801		—
Total long-term liabilities	178,868		38,411
Total liabilities	254,209		76,952
Shareholders' equity:
Common stock, $0.001 par value; 40,000 shares authorized; 13,900 and 13,047 shares issued and outstanding at June 30, 2023 and September 30, 2022, respectively	14		13
Additional paid-in capital	100,072		91,057
Retained earnings	5,080		990
Total shareholders’ equity	105,166		92,060
Total liabilities and shareholders' equity	$	359,375	$	169,012

The accompanying notes are an integral part of these consolidated financial statements.

4

DLH HOLDINGS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands) 

	(unaudited)
	Nine Months Ended
	June 30,
	2023		2022
Operating activities
Net income	$	4,090	$	19,846
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	11,281		5,740
Amortization of deferred financing costs charged to interest expense	1,540		497
Stock-based compensation expense	2,020		1,952
Deferred taxes, net	—		(1)
Changes in operating assets and liabilities:
Accounts receivable	(1,918)		(16,890)
Other current assets	130		(152)
Accrued payroll	274		4,032
Deferred revenue	—		(22,273)
Accounts payable and accrued liabilities	(4,221)		2,380
Other long-term assets and liabilities	1,801		110
Net cash provided by (used in) operating activities	14,997		(4,759)
Investing activities
Business acquisition, net of cash acquired	(180,711)		—
Purchase of equipment and improvements	(580)		(244)
Net cash used in investing activities	(181,291)		(244)
Financing activities
Proceeds from revolving line of credit	144,697		—
Repayment of revolving line of credit	(128,204)		—
Proceeds from debt obligations	168,000		13,500
Repayments of debt obligations	(10,688)		(31,750)
Payments of deferred financing costs	(7,666)		—
Proceeds from issuance of common stock upon exercise of options and warrants	1,107		543
Payment of tax obligations resulting from net exercise of stock options	(650)		(281)
Net cash provided by (used in) financing activities	166,596		(17,988)
Net change in cash	302		(22,991)
Cash - beginning of period	228		24,051
Cash - end of period	$	530	$	1,060
Supplemental disclosure of cash flow information
Cash paid during the period for interest	$	10,006	$	1,195
Cash paid during the period for income taxes	$	4,055	$	6,403
Supplemental disclosure of non-cash activity
Common stock surrendered for the exercise of stock options	$	238	$	256

The accompanying notes are an integral part of these consolidated financial statements.

5

DLH HOLDINGS CORP.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(In thousands) 

(unaudited)

	Common Stock			Additional Paid-In Capital		Retained Earnings		Total Shareholders' Equity
(unaudited)	Shares	Amount
Nine Months Ended June 30, 2023
Balance at September 30, 2022	13,047	$	13	$	91,057	$	990	$	92,060
Issuance and fair value adjustment of common stock in business combination	527	1		6,538		—		6,539
Expense related to director restricted stock units	—	—		539		—		539
Expense related to employee stock options	—	—		1,481		—		1,481
Exercise of stock options	393	—		1,107		—		1,107
Common stock surrendered for the exercise of stock options	(67)	—		(650)		—		(650)
Net income	—	—		—		4,090		4,090
Balance at June 30, 2023	13,900	$	14	$	100,072	$	5,080	$	105,166
Three Months Ended June 30, 2023
Balance at March 31, 2023	13,793	$	14	$	98,584	$	3,342	$	101,940
Expense related to director restricted stock units	—	—		179		—		179
Expense related to employee stock options	—	—		489		—		489
Exercise of stock options	107	—		820		—		820
Net income	—	—		—		1,738		1,738
Balance at June 30, 2023	13,900	$	14	$	100,072	$	5,080	$	105,166

	Common Stock			Additional Paid-In Capital		Accumulated Deficit		Total Shareholders' Equity
(unaudited)	Shares	Amount
Nine Months Ended June 30, 2022
Balance at September 30, 2021	12,714	$	13	$	87,893	$	(22,298)	$	65,608
Expense related to director restricted stock units	—	—		486		—		486
Expense related to employee stock-based compensation	—	—		1,466		—		1,466
Exercise of stock options	224	—		343		—		343
Common stock surrendered for the exercise of stock options	(31)	—		(281)		—		(281)
Exercise of stock warrants	54	—		200		—		200
Net income	—	—		—		19,846		19,846
Balance at June 30, 2022	12,961	$	13	$	90,107	$	(2,452)	$	87,668
Three Months Ended June 30, 2022
Balance at March 31, 2022	12,794	$	13	$	89,664	$	(7,316)	$	82,361
Expense related to director restricted stock units	—	—		162		—		162
Expense related to employee stock-based compensation	—	—		481		—		481
Exercise of stock options	198	—		81		—		81
Common stock surrendered for the exercise of stock options	(31)	—		(281)		—		(281)
Net income	—	—		—		4,864		4,864
Balance at June 30, 2022	12,961	$	13	$	90,107	$	(2,452)	$	87,668

The accompanying notes are an integral part of these consolidated financial statements.

6

DLH HOLDINGS CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

June 30, 2023

1. Basis of Presentation and Principles of Consolidation

The accompanying consolidated financial statements include the accounts of DLH Holdings Corp. and its wholly-owned subsidiaries (together with its subsidiaries, "DLH" or the "Company" and also referred to as "we," "us" and "our"). All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.

In management's opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the period ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending September 30, 2023 or any future period. Amounts as of and for the three and nine months ended June 30, 2023 and June 30, 2022 are unaudited. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022 filed with the Securities and Exchange Commission on December 5, 2022.

2. Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The most significant of these estimates and assumptions relate to estimating revenues and costs including overhead and its allocation, estimating progress toward the completion of performance obligations, assessing fair value of acquired assets and liabilities accounted for through business acquisitions, valuing and determining the amortization periods for long-lived intangible assets, interest rate swaps, stock-based compensation, right-of-use assets and leases liabilities, and loss development on workers' compensation claims. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current and expected future outcomes, third-party evaluations, and various other assumptions that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. We revise material accounting estimates if changes occur, such as more experience is acquired, additional information is obtained, or there is new information on which an estimate was or can be based. Actual results could differ from those estimates.

Revenue

The Company's revenues from contracts with customers are derived from offerings that include technology-enabled business process outsourcing, program management solutions, and public health research and analytics, substantially within the U.S. government and its agencies. The Company has various types of contracts including time-and-materials contracts, cost-reimbursable contracts, and firm-fixed-price contracts.

We consider a contract with a customer to exist when there is a commitment by both parties (customer and Company), payment terms are determinable, there is commercial substance, and collectability is probably in accordance with Accounting Standards Codification ("ASC") No. 606, Revenue from Contracts with Customers ("Topic 606").

We recognize revenue over time when there is a continuous transfer of control to our customer as performance obligations are satisfied. For our U.S. government contracts, this continuous transfer of control to the customer is transferred over time and revenue is recognized based on the extent of progress toward completion of the performance obligation. We consider control to transfer when we have a right to payment. In some instances, the Company commences providing services prior to formal approval to begin work from the customer. The Company considers these factors, the risks associated with commencing work, and legal enforceability in determining whether a contract exists under Topic 606.

Contract modification can occur throughout the life of the contract and can affect the transaction price, extend the period of performance, adjust funding, or create new performance obligations. We review each modification to assess the impact of these

7

contract changes to determine if it should be treated as part of the original performance obligation or as a separate contract. Contract modifications impact performance obligations when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price and our measure of progress for the performance obligation to which it relates is recognized as an adjustment to revenue and profit cumulatively. Furthermore, a significant change in one or more estimates could affect the profitability of our contracts. We recognize adjustments in estimated profit on contracts in the period identified.

For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress based on the contract type.

•Time and material - We bill the customer per labor hour and per material, and revenue is recognized in the amount invoiced as the amount corresponds directly to the value of our performance to date. Revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred.

•Cost reimbursable - We record reimbursable costs as incurred, including an estimated share of the contractual fee earned.

•Firm fixed price - We recognize revenue over time using a straight-line measure of progress

Contract costs generally include direct costs such as labor, materials, subcontract costs, and indirect costs identifiable with or allocable to a specific contract. Costs are expensed as incurred and include an estimate of the contractual fees earned. Contract costs incurred for U.S. government contracts, including indirect costs, are subject to audit and adjustment by various government audit agencies. Historically, our adjustments have not been material.

Contract assets - Amounts are invoiced as work progresses in accordance with agreed-upon contractual terms. In part, revenue recognition occurs before we have the right to bill, resulting in contract assets. These contract assets are reported within Accounts receivable, net on our consolidated balance sheets and are invoiced in accordance with payment terms defined in each contract. Period end balances will vary from period to period due to agreed-upon contractual terms.

Contract liabilities - Amounts are a result of billings in excess of costs incurred or prepayment for services to be rendered.

Fair Value of Financial Instruments

The carrying amounts of the Company's cash and cash equivalents, accounts receivable, contract assets, contract liabilities, accrued expenses, and accounts payable approximate fair value due to the short-term nature of these instruments. The fair values of the Company's debt instruments approximate fair value because the underlying interest rates approximate market rates that the Company could obtain for similar instruments at the balance sheet dates.

Long-lived Assets

Our long-lived assets include equipment and improvements, intangible assets, right-of-use assets, and goodwill. The Company continues to review long-lived assets for possible impairment or loss of value at least annually, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit's carrying amount is greater than its fair value.

Equipment and improvements are recorded at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Maintenance and repair costs are expensed as incurred. Intangible assets (other than goodwill) are originally recorded at fair value and are amortized on a straight-line basis over their estimated useful lives of 10 years. Maintenance and repair costs are expensed as incurred.

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs paid, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.

8

Lease Liabilities

The Company has leases for facilities and office equipment. Our lease liabilities are recognized as the present value of the future minimum lease payments over the lease term. Our lease payments consist of fixed and in-substance fixed amounts attributable to the use of the underlying asset over the lease term. Variable lease payments that do not depend on an index rate or are not in-substance fixed payments are excluded in the measurement of right-of-use assets and lease liabilities and are expensed in the period incurred. The incremental borrowing rate on our secured term loan is used in determining the present value of future minimum lease payments. Some of our lease agreements include options to extend the lease term or terminate the lease. These options are accounted for in our right-of-use assets and lease liabilities when it is reasonably certain that the Company will extend the lease term or terminate the lease. The Company does not have any finance leases.

Goodwill

The Company reviews goodwill for impairment on an annual basis and on a quarterly basis the Company assesses the impact of any macroeconomic changes that may impact the business conditions to determine if these changes have any adverse impact to goodwill. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. The Company determined that no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Provision for Income Taxes

The Company accounts for income taxes in accordance with the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheets when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. We account for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon the technical merits, it is more-likely-than-not that the position will be sustained upon examination. We had no uncertain tax positions at either June 30, 2023 or September 30, 2022. We report interest and penalties as a component of provision for income taxes. During the three and nine months ended June 30, 2023 and June 30, 2022, we recognized no interest and no penalties related to income taxes.

Stock-based Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock option or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to common stock.

Compensation expense for the portion of equity awards for which the requisite service has not been rendered is recognized as the requisite service is rendered. The compensation expense for that portion of awards has been based on the grant-date fair value of those awards as calculated for recognition purposes under applicable guidance. For options that vest based on the Company’s common stock achieving and maintaining defined market prices, the Company values the awards with a Monte Carlo method that utilizes various probability factors and other criterion in establishing fair value of the grant. The related compensation expense is recognized over the service period.

9

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000.

Accounts Receivable

Receivables include amounts billed and currently due from customers where the right to consideration is unconditional and amounts unbilled. Both billed and unbilled amounts are non-interest bearing, unsecured, and recognized at an estimated realizable value that includes costs and fees, and are generally expected to be billed and received within a single year. We evaluate our receivables on a quarterly basis and determine whether an allowance is appropriate based on specific collection issues. No allowance for doubtful accounts was deemed necessary at either June 30, 2023 or September 30, 2022.

Earnings Per Share

Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common stock outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Treasury Stock

The Company periodically purchases its own common stock that is traded on public markets as part of announced stock repurchase programs. The repurchased common stock is classified as treasury stock on the consolidated balance sheets and held at cost. As of June 30, 2023 and September 30, 2022, the Company did not hold any treasury stock.

Preferred Stock

Our certificate of incorporation authorizes the issuance of "blank check" preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors up to an aggregate of 5,000,000 shares of preferred stock. As of June 30, 2023 and September 30, 2022, the Company has not issued any preferred stock.

Interest Rate Swap

The Company uses derivative financial instruments to manage interest rate risk associated with its variable debt. The Company's objective in using these interest rate derivatives is to manage its exposure to interest rate movements and reduce volatility of interest expense. The gains and losses due to changes in the fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt are recognized in interest expense in the consolidated statements of operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Risks & Uncertainties

Management evaluates the impact of global markets and economic factors on our industry and the potential for adverse effects on the Company's consolidated financial position and its operations. As of June 30, 2023, there was no indication of any global or economic impacts to our industry.

3. New Accounting Pronouncements

In March 2020 and January 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and ASU No. 2021-01, “Reference Rate Reform (Topic 848): Scope,” respectively (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In December 2022, FASB issued ASU 2022-06 "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" which defers the end date for electing the relief provided in Topic 848 from

10

December 31, 2022 to December 31, 2024. In the first quarter of fiscal 2023, the Company adopted the optional expedients and exceptions provided in Topic 848. The adoption did not have a material impact on the Company’s consolidated financial statements.

4. Business Combination

Acquisition of Grove Resource Solutions, LLC

On December 8, 2022, the Company acquired 100% of the equity interests of Grove Resource Solution, LLC ("GRSi") for a purchase price of $188.0 million, inclusive of the working capital adjustment completed and paid during this fiscal quarter. The acquisition was financed through a combination of:

•borrowings of $181.5 million under the Company’s amended and restated credit facility; and

•common stock issued of approximately 0.5 million shares, which were valued at $6.5 million in the aggregate, based on the shares issued to the previous owners as determined by the equity purchase agreement and the stock price on the acquisition date.

The acquisition of GRSi was consistent with the Company’s growth strategy, as it provided contract diversification, addition of key capabilities and increased presence in the military health market. The estimated goodwill derived from this transaction is primarily due to these attributes.

The Company has used the acquisition method of accounting for this transaction, whereby the assets acquired and liabilities assumed are recognized based upon their estimated fair values at the acquisition date.

The purchase price for GRSi was $188.0 million adjusted to reflect acquired cash, assumed liabilities and net working capital adjustments.

The Purchase Agreement contains customary representations, warranties and covenants by the parties. Subject to certain limitations and conditions, the seller and the equity holders of the seller do not have indemnity obligation for damages resulting from breaches or inaccuracies of the representations, warranties, and covenants of the seller, GRSI and the equity holders as set forth in the Purchase Agreement. The Purchase Agreement also provided for the establishment of an escrow account in order to satisfy (i) any downward adjustment of the purchase price base on GRSI's net working capital at the closing and (ii) certain specified indemnification obligations of the seller and equity holders that may arise following the closing. The escrow account is funded by an aggregate amount of approximately $4.3 million and the stock consideration. A representations and warranties insurance policy has been purchased by the Company in connection with the Purchase Agreement, under which the Company may seek recourse for breaches of the representations and warranties of the seller, GRSI and the equity holders. The representations and warranties insurance policy is subject to certain customary exclusions and a deductible.

In accordance with ASU 2017-01, the Company evaluated the transaction as an acquisition of a business. The Company has assessed the acquisition price to the fair value of the assets and liabilities of GRSi at the acquisition date. Based on the unaudited financial statements of GRSi on December 8, 2022, we accounted for the total acquisition consideration and allocation of fair value of the related assets and liabilities as follows (in thousands):

11

Purchase price for GRSi	$	187,997
Purchase price allocation:
Cash	747
Accounts receivable	25,468
Other current assets	1,354
Accounts payable and accrued expenses	(2,449)
Payroll liabilities	(7,826)
Other current liabilities	(325)
Equipment and improvements, net	463
Other long-term assets and liabilities	(781)
Intangible assets	98,688
Total identifiable net assets acquired	115,339
Goodwill	$	72,658

All operating units are aggregated into a single reportable segment. The acquisition of GRSi did not create an additional reportable segment as all operations report to a single Chief Operating Decision Maker (CODM), serve a similar customer base, and provide similar services within a common regulatory environment. The goodwill represents intellectual capital and the acquired workforce, of which both do not qualify as a separate intangible asset.

During the three months ended and nine months ended June 30, 2023, following the completion of the acquisition, GRSi contributed approximately $34.4 million and $73.9 million of revenue and $2.6 million and $4.1 million of income from operations, respectively.

The following table presents certain results for the three and nine months ended June 30, 2023 and 2022 as though the acquisition of GRSi had occurred on October 1, 2021. The unaudited pro forma information is presented for informational purposes only and is not necessarily indicative of our results if the acquisition had taken place on that date. The pro forma information was prepared by combining our reported historical results with the historical results of GRSi for the pre-acquisition periods. In addition, the reported historical amounts were adjusted for the following items, net of associated tax effects:

•The impact of recording GRSi's intangible asset amortization.

•The impact of interest expense for the new credit facility.

•The removal of legacy GRSi director's fees.

•The removal of transaction costs for the acquisition incurred by GRSi.

	(unaudited)				(unaudited)
	(in thousands)				(in thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
Pro forma results	2023		2022		2023		2022
Revenue	$	102,241	$	94,326	$	301,481	$	407,795
Net income	1,738		4,603		4,683		15,455
Number of shares outstanding - basic	13,854		12,812		13,638		12,779
Number of shares outstanding - diluted	14,539		14,235		14,421		14,205
Basic earnings per share	$0.13		$0.36		$0.34		$1.21
Diluted earnings per share	$0.12		$0.32		$0.32		$1.09

12

5. Revenue Recognition

The following table summarizes the contract balances recognized on the Company's consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Contract assets	$	19,300	$	7,682

Contract assets are included presented as part of the accounts receivables on the consolidated balances sheets. Contract liabilities are presented as deferred revenue, which had no balance as of June 30, 2023 and September 30, 2022.

Disaggregation of Revenue from Contracts with Customers

We disaggregate our revenue from contracts with customers by customer, contract type, as well as whether the Company acts as prime contractor or subcontractor. We believe these categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. The following series of tables present our revenue disaggregated by these categories:

Revenue by customer for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Department of Veterans Affairs	$	35,898	$	33,344	$	104,489	$	92,270
Department of Health and Human Services	44,536		27,741		115,528		78,452
Department of Defense	21,003		8,272		50,802		25,227
Department of Homeland Security	256		(4,908)		639		126,397
Other	548		1,991		2,927		5,594
Total	$	102,241	$	66,440	$	274,385	$	327,940

Revenue by contract type for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Time and Materials	$	51,572	$	44,672	$	154,366	$	263,072
Cost Reimbursable	29,110		11,979		58,951		34,364
Firm Fixed Price	21,559		9,789		61,068		30,504
Total	$	102,241	$	66,440	$	274,385	$	327,940

Revenue by whether the Company acts as a prime contractor or a subcontractor for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Prime Contractor	$	97,885	$	58,743	$	259,692	$	304,862
Subcontractor	4,356		7,697		14,693		23,078
Total	$	102,241	$	66,440	$	274,385	$	327,940

13

6. Leases

The following table summarizes lease balances presented on our consolidated balance sheets was as follows (in thousands):

	June 30,		September 30,
	2023		2022
Operating lease right-of-use assets	$	17,911	$	16,851
Operating lease liabilities, current	$	3,478	$	2,235
Operating lease liabilities - long-term	16,485		16,461
Total operating lease liabilities	$	19,963	$	18,696

As of June 30, 2023, operating leases for facilities and equipment have remaining lease terms of less than 1 to 7.9 years.

For the three and nine months ended June 30, 2023 and 2022, total lease costs for our operating leases was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Operating	$	1,097	$	869	$	2,921	$	2,684
Short-term	83		33		225		85
Variable	47		44		63		89
Sublease income (a)	(71)		(69)		(214)		(188)
Total lease costs	$	1,156	$	877	$	2,995	$	2,670

(a) The Company subleases a portion of one of its leased facilities. The sublease is classified as an operating lease with respect to the underlying asset. The sublease term is 5 years and includes two additional 1-year term extension options.

The Company's future minimum lease payments as of June 30, 2023 as follows (in thousands):

For the Fiscal Year Ending September 30,
2023 (remaining)	$	1,165
2024	4,611
2025	3,928
2026	3,700
2027	2,627
Thereafter	8,672
Total future lease payments	24,703
Less: imputed interest	(4,740)
Present value of future minimum lease payments	19,963
Less: current portion of operating lease liabilities	(3,478)
Long-term operating lease liabilities	$	16,485

At June 30, 2023, the weighted-average remaining lease term and weighted-average discount rate are 6.3 years and 6.4% respectively. The calculation of the weighted-average discount rate was determined based on borrowing terms from our secured term loan.

14

Other information related to our leases for the nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	2023	2022
Cash paid for amounts included in the measurement of lease liabilities	3,317	$	2,566
Lease liabilities arising from obtaining right-of-use assets	2,052	$	—

7. Supporting Financial Information

Accounts receivable

The following table summarizes accounts receivable presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Billed receivables	$	48,582	$	32,814
Contract assets	19,300		7,682
Allowance for doubtful accounts	—		—
Accounts receivable	$	67,882	$	40,496

Other current assets

The following table summarizes other current assets presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Prepaid insurance and benefits	$	1,316	$	737
Prepaid licenses and other expenses	1,694		1,196
Other receivables	1,072		945
Other current assets	$	4,082	$	2,878

Equipment and improvements, net

The following table summarizes equipment and improvements, net presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Furniture and equipment	$	877	$	893
Computer equipment	5,328		2,316
Computer software	1,733		4,407
Leasehold improvements	1,878		1,614
Total equipment and improvements	9,816		9,230
Less: accumulated depreciation and amortization	(8,126)		(7,526)
Equipment and improvements, net	$	1,690	$	1,704

Depreciation and amortization expense was $0.2 million for each of the three months ended June 30, 2023 and 2022. Depreciation and amortization expense was $0.6 million and $0.8 million for the nine months ended June 30, 2023 and 2022, respectively.

15

Intangible assets

The following table summarizes intangible assets, net presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Intangible assets
Customer contracts and related customer relationships	$	113,622	$	47,044
Covenants not to compete	637		522
Trade name	13,034		3,051
Backlog	37,249		15,237
Total intangible assets	164,542		65,854
Less: accumulated amortization
Customer contracts and related customer relationships	(27,087)		(19,731)
Covenants not to compete	(362)		(316)
Trade name	(1,859)		(1,048)
Backlog	(6,343)		(3,875)
Total accumulated amortization	(35,651)		(24,970)
Intangible assets, net	$	128,891	$	40,884

Amortization expense was $4.1 million and $1.6 million for the three months ended June 30, 2023 and 2022, respectively. Amortization expense was $10.7 million and $4.9 million for the nine months ended June 30, 2023 and 2022, respectively.

As of June 30, 2023, the estimated amortization expense per fiscal year as follows (in thousands):

2023 (remaining)	$	4,096
2024	16,386
2025	16,385
2026	15,652
2027	14,624
Thereafter	61,748
Total amortization expense	$	128,891

Goodwill

The change in the carrying amount of goodwill as follows presented on our consolidated balance sheets as follows (in thousands):

Balance at September 30, 2022	$	65,643
Increase from GRSi acquisition (a)	72,658
Balance at June 30, 2023	$	138,301

Ref (a) ; The Company has completed its valuation assessment of the GRSi acquisition. Please refer to Note 4 for more information.

16

Accounts payable and accrued liabilities

The following table summarizes accounts payable and accrued liabilities presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Accounts payable	$	15,559	$	11,886
Accrued benefits	4,073		3,857
Accrued bonus and incentive compensation	3,147		3,625
Accrued workers' compensation insurance	2,749		4,880
Other accrued expenses	74		2,614
Accounts payable and accrued liabilities	$	25,602	$	26,862

Debt obligations

The following table summarizes debt obligations presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Secured revolving line of credit	$	16,448	$	—
Secured term loan	179,312		22,000
Less: unamortized deferred financing costs	(7,665)		(1,584)
Net bank debt obligations	188,095		20,416
Less: current portion of debt obligations, net of deferred financing costs (a)	(28,716)		—
Long-term portion of debt obligations, net of deferred financing costs	$	159,379	$	20,416

(a) Current portion comprises term loan amortization of $14.3 million and the $16.4 million outstanding balance on the secured revolving line of credit, net of $2.0 million of unamortized deferred financing costs.

Interest expense

The following table summarizes interest expense presented on our consolidated statements of operations for the three and nine months ended June 30, 2023 and 2022 as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Interest expense (a)	$	4,282	$	334	$	9,972	$	1,242
Amortization of deferred financing costs (b)	635		178		1,540		497
Interest expense	$	4,917	$	512	$	11,512	$	1,739

(a) Interest expense on borrowing.

(b) Amortization of expenses related to secured term loan and secured revolving line of credit.

8. Credit Facilities

A summary of our credit facilities as of June 30, 2023 and September 30, 2022 is as follows (in millions):

17

June 30, 2023				September 30, 2022
Arrangement	Loan Balance		Interest	Arrangement	Loan Balance		Interest
Secured term loan (a) due December 8, 2027	$	179.3	SOFR* + 4.2%	Secured term loan due September 30, 2025	$	22.0	LIBOR + 2.5%
Secured revolving line of credit (b) due December 8, 2027	$	16.4	SOFR* + 4.2%	Secured Revolving line of Credit due September 20, 2025	$	—	LIBOR + 2.5%

*Secured Overnight Financing Rate ("SOFR") as of June 30, 2023 was 5.2%.

On September 30, 2019, we executed a floating-to-fixed interest rate swap with First National Bank ("FNB") as counter-party. The notional amount in the floating-to-fixed interest rate swap as of June 30, 2023 is $16.2 million matures in 2024, and the fixed rate is 1.61%. On January 31, 2023, we executed an additional floating-to-fixed interest rate swap with FNB; the notional amount as of June 30, 2023 is $96.0 million, it matures in January 2026, and the fixed rate is 4.10% The total floating-to-fixed swap balance as of June 30, 2023 is $112.2 million. As a result of entering these agreements, for the nine months ended June 30, 2023, interest expense has been decreased by approximately $0.6 million.

(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027.

The Credit Agreement requires compliance with a number of financial covenants and contains restrictions on our ability to engage in certain transactions. Among other matters, we must comply with limitations on the following: granting liens; incurring other indebtedness; maintenance of assets; investments in other entities and extensions of credit; mergers and consolidations; and changes in nature of business. The loan agreement also requires us to comply with certain quarterly financial covenants including: (i) a minimum fixed charge coverage ratio of at least 1.25 to 1.00, and (ii) a total leverage ratio not exceeding the ratio of 4.50:1.0 to 2.00:1.0 through maturity. The total leverage ratio is calculated by dividing the Company's total interest-bearing debt by net income adjusted to exclude (i) interest and other expenses, (ii) provision for or benefit from income taxes, if any, (iii) depreciation and amortization, and (iv) non-cash charges, losses or expenses, including stock-based compensation, and (v) non-recurring charges, losses or expenses to include transaction and non-cash equity expense. We are in compliance with all loan covenants and restrictions.

We are required to pay quarterly amortization payments, which commenced in December 2022. The annual amortization amounts are $14.3 million each for fiscal years 2023 and 2024, $19.0 million each for fiscal years 2025 and 2026, and $23.8 million for fiscal year 2027, with the remaining unpaid loan balance due at maturity in December 2027. The quarterly payments are equal installments. The Company made a mandatory prepayment of $3.6 million during the quarter ended June 30, 2023 bringing the outstanding principal balance on the secured term loan to $179.3 million. We have satisfied mandatory principal amortization until June 30, 2023.

In addition to quarterly payments of the outstanding indebtedness, the loan agreement also requires annual payments of a percentage of excess cash flow, as defined in the loan agreement. The loan agreement states that an excess cash flow recapture payment must be made equal to (a) 75% of the excess cash flow for the immediately preceding fiscal year in which the total leverage ratio is greater than or equal to 2.50:1.0; (b) 50% of the excess cash flow for the immediately preceding fiscal year in which the total leverage ratio is less than 2.50:1.0 but greater than or equal to 1.5:1.0; or (c) 0% of the excess cash flow for the immediately preceding fiscal year in which the total leverage ratio is less than 1.5:1.0. In addition, the Company must make additional mandatory prepayment of amounts outstanding based on proceeds received from asset sales and sales of certain indebtedness. For additional information regarding the schedule of future payment obligations, please refer to Note 11. Commitments and Contingencies.

(b) The secured revolving line of credit has a ceiling of up to $70.0 million; as of June 30, 2023 we had unused borrowing capacity of $32.9 million, which is net of outstanding letters of credit. Borrowing on the line of credit is secured by liens on substantially all of the assets of the Company. The Company accessed funds from the revolving credit facility during the quarter and had an outstanding balance at June 30, 2023 of $16.4 million.

18

The Company's total borrowing availability, based on eligible accounts receivable at June 30, 2023, was $32.9 million. As part of the revolving credit facility, the lenders agreed to a sublimit of $10.0 million for letters of credit for the account of the Company, subject to applicable procedures.

The revolving line of credit has a maturity date of December 8, 2027 and is subject to loan covenants as described above. The Company is fully compliant with those covenants.

9. Stock-Based Compensation and Equity Grants

Stock-based compensation expense

Options issued under equity incentive plans were designated as either incentive stock or non-statutory stock options. No option is granted with a term of more than 10 years from the date of grant. Exercisability of option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued shares. As of June 30, 2023, there were 0.9 million shares available for grant under the 2016 Omnibus Equity Incentive Plan.

Stock-based compensation expense, shown in the table below, is recorded in general and administrative expenses included in our consolidated statements of operations for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	(in thousands)				(in thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
DLH employees (a)	$	489	$	481	$	1,481	$	1,466
Non-employee directors (b)	179		162		539		486
Total stock option expense	$	668	$	643	$	2,020	$	1,952

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, and stock option grants to employees during prior fiscal years. The RSUs totaled 337,578 and 161,485 issued and outstanding at June 30, 2023 and 2022, respectively. During the nine months ended June 30, 2023, 197,174 RSUs were granted to Executive Officers. Of the RSUs granted, 141,892 have performance-based vesting criteria and the remaining 55,282 have service-based vesting criteria. Utilizing a volatility of 50% along with assumptions of a 3-year term and the performance vesting criteria results in an indicated range of value, the RSUs granted during nine months ended June 30, 2023, as follows using the Monte Carlo Method.

				Volatility
				50%
				Calculated
Grant Date	Performance Vesting Base	Performance Vesting Criteria	(Years)	Fair Value
January 27, 2023	Revenue	Revenue increase at the end of the performance period as compared to the year ended September 30, 2022	3	$	3.51
January 27, 2023	Stock price	Stock price is at least $33.21 per share average for the 30 days prior to the end of the performance period	3	$	2.92
Notes:
Results based on 100,000 simulations

19

(b) Equity grants of RSUs were made in accordance with DLH compensation policy for non-employee directors and a total of 50,367 and 53,510 restricted stock units were issued and outstanding at June 30, 2023 and 2022, respectively. These grants have service-based vesting criteria and vest at the end of this fiscal year.

Unrecognized stock-based compensation expense

Unrecognized stock-based compensation expense is presented in the table below for the three months ended June 30, 2023 and 2022 as follows (in thousands):

	2023		2022
Unrecognized expense for DLH employees (a)	$	7,358	$	5,498
Unrecognized expense for non-employee directors	155		162
Total unrecognized expense	$	7,513	$	5,660

(a) On a weighted average basis, the unrecognized expense for the three months ended June 30, 2023 is expected to be recognized within the next 4.1 years.

Stock option activity for the nine months ended June 30, 2023

The aggregate intrinsic value in the table below represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their in the money options on those dates. This amount will change based on the fair market value of the Company’s stock.

				(in years)
				Weighted
		Weighted		Average	(in thousands)
	(in thousands)	Average		Remaining	Aggregate
	Number of	Exercise		Contractual	Intrinsic
	Shares	Price		Term	Value
Options outstanding, September 30, 2022	2,392	$	7.05	5.40	$	13,566
Granted (a)	400	11.66		—	—
Exercised (b)	(393)	3.42		—	—
Cancelled	(158)	9.07		—	—
Options outstanding, June 30, 2023	2,241	$	8.36	5.92	$	6,499

20

Ref (a): Utilizing a volatility of 50% along with assumptions of a 10-year term and the aforementioned 10-day stock price threshold results in an indicated range of value of the Options granted during three months ended March 31, 2023, as follows using the Monte Carlo Method.

								Volatility
								50%
					Vesting		Expected
	Strike		Stock		Threshold		Term	Calculated
Grant Date	Price		Price		Price		(Years)	Fair Value
January 26, 2023	$	11.66	$	11.66	$	15.00	10	$	7.41
Notes:
Results based on 100,000 simulations

Ref (b): The intrinsic value of options exercised for the three and nine months ended June 30, 2023 were $0.2 million and $3.4 million.

Stock options shares outstanding, vested and unvested for the periods ended as follows (shares in thousands):

	June 30,	September 30,
	2023	2022
Vested and exercisable (a)	1,616	2,117
Unvested (b)	625	275
Options outstanding	2,241	2,392

(a) The weighted average exercise price of vested and exercisable shares was $6.45 and $5.86 at June 30, 2023 and September 30, 2022, respectively. Aggregate intrinsic value was approximately $6.5 million and $13.6 million at June 30, 2023 and September 30, 2022, respectively. The weighted average contractual term remaining was 4.6 years and 4.9 years at June 30, 2023 and September 30, 2022, respectively.

(b) Certain awards vest upon satisfaction of certain performance criteria.

21

10. Earnings Per Share

Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common shares outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Earnings per share information is presented in the table below for the three and nine months ended June 30, 2023 and 2022 as follows (in thousands except for per share amounts):

	(In thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Numerator:
Net income	$	1,738	$	4,864	$	4,090	$	19,846
Denominator:
Denominator for basic net income per share - weighted-average outstanding shares	13,854		12,812		13,638		12,779
Effect of dilutive securities:
Stock options and restricted stock	685		1,423		783		1,426
Denominator for diluted net income per share - weighted-average outstanding shares	14,539		14,235		14,421		14,205
Net income per share - basic	$	0.13	$	0.38	$	0.30	$	1.55
Net income per share - diluted	$	0.12	$	0.34	$	0.28	$	1.40

11. Commitments and Contingencies

Contractual obligations as of June 30, 2023 are as follows (in thousands):

			Payments Due Per Fiscal Year
			(Remaining)
	Total		2023		2024		2025		2026		2027		Thereafter
Debt obligations	$	195,760	$	3,563	$	14,250	$	19,000	$	19,000	$	23,750	$	116,197
Facility operating leases	24,636		1,148		4,561		3,928		3,700		2,627		8,672
Equipment operating leases	67		17		50		—		—		—		—
Total contractual obligations	$	220,463	$	4,728	$	18,861	$	22,928	$	22,700	$	26,377	$	124,869

Workers' Compensation

We accrue workers' compensation expense based on claims submitted, applying actuarial loss development factors to estimate the costs incurred but not yet recorded. Our accrued liability for claims development as of June 30, 2023 and September 30, 2022 was $2.7 million and $4.9 million, respectively.

Legal Proceedings

As a commercial enterprise and employer, the Company is subject to various claims and legal actions in the ordinary course of business. These matters can include professional liability, workers’ compensation, tax, payroll and employee-related matters, other commercial disputes arising in the course of its business, and inquiries and investigations by governmental agencies

22

regarding our employment practices or other matters. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position, or cash flows.

12. Related Party Transactions

The Company has determined that for the three and nine months ended June 30, 2023 and June 30, 2022 there were no significant related party transactions that have occurred which require disclosure through the date that these consolidated financial statements were issued.

ITEM 2:  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking and Cautionary Statements

You should read the following discussion in conjunction with the Consolidated Financial Statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q, as well as our Annual Report on Form 10-K for the year ended September 30, 2022, and in other reports we have subsequently filed with the SEC. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in this Management’s Discussion and Analysis are forward-looking statements that involve risks and uncertainties. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this report include, among others, statements regarding benefits of the acquisition, estimates of future revenues, operating income, earnings, earnings per share, backlog, and cash flows. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this report due to a variety of factors, including: the continuation of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, which are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the failure to achieve the anticipated benefits of our acquisition of GRSi or any future acquisition (including anticipated future financial operating performance and results); the diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and more widespread operations resulting from our recent acquisition; the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our increased debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of GRSi or any future acquisitions; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Business and Markets Overview

DLH enhances public health and national security readiness missions through science, technology, cyber, and engineering solutions and services. We are primarily focused on improving and better deploying large-scale federal health and human service initiatives. The Company derives 99% of its revenue from agencies of the Federal government, providing services to several agencies including the Department of Veteran Affairs ("VA"), Department of Health and Human Services ("HHS"), Department of Defense ("DoD"), and Department of Homeland Security, ("DHS"). The following table summarizes revenue by customer for the three months ended June 30, 2023 and 2022 as follows (in thousands and percent):

23

	2023				2022
	Revenue		Percent of total revenue		Revenue		Percent of total revenue
Department of Veterans Affairs	$	35,898	35.1	%	$	33,344	50.2	%
Department of Health and Human Services	44,536		43.6	%	27,741		41.8	%
Department of Defense	21,003		20.5	%	8,272		12.5	%
Department of Homeland Security	256		0.3	%	(4,908)		(7.4)	%
Other customers with less than 10% share of total revenue	548		0.5	%	1,991		2.9	%
Total revenue	$	102,241	100.0	%	$	66,440	100.0	%

We provide solutions to three market focus areas: Defense and Veteran Health Solutions, Human Solutions and Services, and Public Health and Life Sciences. We deliver domain-specific expertise, industry best-practices and innovations to customers across these markets leveraging seven core competencies: secure data analytics, clinical trials and laboratory services, case management, performance evaluation, system modernization, operational logistics and readiness, and strategic digital communications. The Company manages its operations from its principal executive office in Atlanta, Georgia, and we have a complementary headquarters office in Silver Spring, Maryland. The Company employs over 3,200 skilled employees working throughout the United States and one location overseas.

Acquisitions

On December 8, 2022, we acquired Grove Resource Solutions, LLC. ("GRSi") to increase future organic growth, diversify our customer base, and to expand into adjacent markets. GRSi provides research and development, systems engineering and integration, and digital transformations solutions to federal agencies, notably the National Institutes of Health ("NIH"), U.S. Navy and U.S. Marine Corps. For further information, refer to Note 4 of the accompanying notes to our consolidated financial statements contained elsewhere in this report.

Major Contracts

We operate primarily through prime contracts awarded by the government through competitive bidding processes. We have a diverse mix of contract vehicles with various agencies of the United State government, which supports our overall corporate growth strategy. Our Federal contract schedules are renewed on a recurring basis for multi-year periods.

The revenue attributable to the VA was derived from 16 separate contracts covering the Company's performance of pharmacy and logistics services in support of the VA's Consolidated Mail Outpatient Pharmacy ("CMOP") program.

•Nine contracts for pharmacy services, which represent revenues of approximately $60.6 million and $51.2 million for the nine months ended June 30, 2023 and 2022, respectively, are currently operating under a bridge contract through October 2023.

•Seven contracts for logistics services, which represent approximately $43.7 million and $41.1 million of revenues for the nine months ended June 30, 2023 and 2022, respectively, are currently operating under a bridge contract through November 2023.

The VA has issued a request for proposal for healthcare logistics and pharmacy services for each CMOP location. The procurement was set-aside for a service-disabled veteran owned small business ("SDVOSB") to be solicited as the prime contractor. DLH maintains relationships with SDVOSB partners. Should the new contracts for performance of these services be awarded to a partner of DLH, the Company expects to continue to perform a significant amount of the contract’s volume of business as a subcontractor. Should the VA conclude that an award to an SDVOSB prime contractor is not in the best interest of the government, they may reissue a solicitation in an unrestricted competition. DLH believes that its service excellence over many years on the program would provide an advantage in an unrestricted competition.

The Company's contract with HHS in support of its Head Start program generated $27.1 million and $25.9 million of its revenue for the nine months ended June 30, 2023 and 2022, respectively. This contract has a period of performance through April 2025.

We remain dependent upon the continuation of our relationships with the VA and HHS. Our results of operations, cash flows, and financial condition would be materially adversely affected if we were unable to continue our relationship with either of

24

these customers, if we were to lose any of our material current contracts, or if the amount of services we provide to them was to be materially reduced.

Backlog

At June 30, 2023, our backlog was approximately $817.8 million, of which $147.3 million was funded backlog. At September 30, 2022, our backlog was approximately $482.5 million, of which $98.9 million was funded backlog.

We define backlog as our estimate of remaining future revenue from existing signed contracts, assuming the exercise of all options relating to such contracts and including executed task orders issued under Indefinite Quantity/Indefinite Delivery ("IDIQ") contracts or if the contract is a single award IDIQ contract.

We define funded backlog as the portion of backlog for which funding is appropriated and allocated to the contract by the customer and authorized for payment by the customer, once specified work is completed. Funded backlog does not include the full contract value as Congress often appropriates funding for contracts on a yearly or quarterly basis.

Circumstances and events may cause changes in the amount of our backlog and funded backlog, including the execution of new contracts, extension of existing contracts, non-renewal or completion of current contracts, early termination, and adjustments to estimates. Changes in funded backlog may be affected by the funding cycles of the government. While no assurances can be given that existing contracts will result in earned revenue in any future period, or at all, our major customers have historically exercised their contractual renewal options.

Backlog value is quantified from management's judgment and assumptions about the volume of services based on past volume trends and current planning developed with customers.

25

Forward-Looking Business Trends

Our mission is to expand our position as a trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to active duty personnel, veterans, and civilian populations and communities. Our primary focus within the defense agency markets include military service members' and veterans' requirements for telehealth services, behavioral healthcare, medication therapy management, process management, clinical systems support, and healthcare delivery. Our primary focus within the civilian agency markets includes healthcare and social programs delivery and readiness. These include compliance monitoring on large scale programs, technology-enabled program management, consulting, and digital communications solutions ensuring that education, health, and social standards are being achieved within underserved and at-risk populations. We believe these business development priorities will position the Company to expand within top national priority programs and funded areas.

Federal budget outlook for 2024

On March 9, 2023, President Biden's administration released its budget request for fiscal year 2024. The administration's budget had several focus areas:

•Lowering health care costs and expand access to healthcare

•Expanding access to affordable, high-quality early child care and learning

•Investing in cutting edge technologies

•Improving our global security posture

While we believe that the services and capabilities we provide are key to the federal government executing its missions and meeting its strategic missions and goals, it is uncertain in any particular government fiscal year that appropriations bills will be passed. When appropriation bills have not passed, government agencies continue to operate under continuing resolutions. Over the coming months, we anticipate that the administration will negotiate with Congressional leaders to develop legislation that will fund the federal government's fiscal 2024 operations.

On June 3, 2023, the President signed H.R. 3746 "The Fiscal Responsibility Act" into law. This bill caps national defense spending at the President's Budget request levels of $886 billion and $895 billion for government fiscal year 2024 and 2025, respectively. The legislation also suspended the debt ceiling until January 1, 2025.

Adverse changes in fiscal and economic conditions could materially impact our business. Some changes that could have an adverse impact on our business include the implementation of future spending reductions (including sequestration), delayed passage of appropriations bills resulting in temporary or full-year continuing resolutions, extreme inflationary increases adversely impacting fixed-price contracts, inability to increase or suspend the Federal debt ceiling, and potential government shutdowns.

Industry consolidation among federal government contractors

There has been active consolidation and a strong increase in merger and acquisition activity among federal government contractors over the past few years that we expect to continue, fueled by public companies leveraging strong balance sheets. Companies often look to acquisitions that augment core capabilities, contracts, customers, market differentiators, stability, cost synergies, and higher margin and revenue streams.

Potential impact of Federal Contractual set-aside Laws and Regulations:

The Federal government has an overall goal of 23% of prime contracts flowing through small businesses. As previously reported, various agencies within the federal government have policies that support small business goals, including the adoption of the “Rule of Two” by the VA, which provides that the agency shall award contracts by restricting competition for the contract to service-disabled or other veteran owned businesses. To restrict competition pursuant to this rule, the contracting officer must reasonably expect that at least two of these businesses, which are capable of delivering the services, will submit offers and that the award can be made at a fair and reasonable price that offers best value to the United States. When two qualifying small businesses cannot be identified, the VA may proceed to award contracts following a full and open bid process.

The Company believes that its past performance in this market and track record of success provide a competitive advantage. However, the effect of set-aside provisions may limit our ability to compete for prime contractor positions on programs that we recompete or that we have targeted for growth. In these cases, the Company may elect to join a team with an eligible contractor

26

as prime in support of such small businesses for specific pursuits that align with our core markets and corporate growth strategy.

Results of Operations

For the Three Months Ended June 30, 2023 as Compared to the Three Months Ended June 30, 2022

The following table summarizes, for the periods indicated, consolidated statements of operations data expressed in dollars in thousands except for per share amounts, and as a percentage of revenue as follows (in thousands and percent):

	Three Months Ended
Consolidated Statements of Operations:	June 30, 2023				June 30, 2022				Change
Revenue	$	102,241	100.0	%	$	66,440	100.0	%	$	35,801
Cost of operations:
Contract costs	80,919		79.1	%	49,668		74.9	%	31,251
General and administrative costs	9,935		9.7	%	7,535		11.3	%	2,400
Corporate development costs	—		—	%	250		0.3	%	(250)
Depreciation and amortization	4,280		4.2	%	1,873		2.8	%	2,407
Total operating costs	95,134		93.0	%	59,326		89.3	%	35,808
Income from operations	7,107		7.0	%	7,114		10.7	%	(7)
Interest expense	4,917		4.9	%	512		0.8	%	4,405
Income before provision for income taxes	2,190		2.1	%	6,602		9.9	%	(4,412)
Income tax expense	452		0.4	%	1,738		2.6	%	(1,286)
Net income	$	1,738	1.7	%	$	4,864	7.3	%	$	(3,126)
Net income per share - basic	$	0.13			$	0.38			$	(0.25)
Net income per share - diluted	$	0.12			$	0.34			$	(0.22)

The following factors have affected our operating results for the third quarter of fiscal year 2023 as compared to the third quarter of our 2022 fiscal year:

•During the quarter ended December 31, 2022, we acquired GRSi. From the date of this acquisition, we have received the benefit of additional revenue, as well as incurred additional operating costs. In addition, we amended and restated our credit facility to fund the acquisition of GRSi and the cost of servicing this debt has resulted in an increase in our interest expense.

•Our results of operations for the quarter ended June 30, 2022 included revenues of approximately ($5.1) million derived from the two task orders awarded under a FEMA contact to support the State of Alaska in its response to the COVID-19 pandemic. These task orders were completed during the quarter ended March 31, 2022 and there was no comparable revenue contribution from this work during the 2023 period.

Due to these developments, in the “Non-GAAP Financial Measures” section below, we have included a discussion of our adjusted financial performance to present our financial performance for the quarters ended June 30, 2023 and 2022 without the impact of the FEMA task orders.

Revenue

Revenue for the quarter ended June 30, 2023 was $102.2 million, an increase of $35.8 million. The increase in revenue is primarily due to the $34.4 million revenue contribution from the acquisition of GRSi. The remaining increase was due to volume increase on legacy customer contracts.

27

Cost of Operations

Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs. For the three months ended June 30, 2023, contract costs increased by approximately $31.3 million, principally due to the inclusion of GRSi.

General and administrative costs are for those employees not directly providing services to our customers, to include but not limited to executive management, bid and proposal, accounting, and human resources. These costs increased as compared to the prior fiscal year period by $2.4 million, primarily due to the inclusion of GRSi.

For the three months ended June 30, 2023, depreciation and amortization costs were approximately $0.2 million and $4.1 million, respectively, as compared to approximately $0.2 millions and $1.6 million for the prior fiscal year period, respectively. The increase in amortization was principally due to the acquired definite-lived intangible assets of GRSi.

Interest Expense

Interest expense includes items such as interest expense and amortization of deferred financing costs on debt obligations.

For the three months ended June 30, 2023 and 2022, interest expense was approximately $4.9 million and $0.5 million, respectively. The increase in interest expense was primarily due to the borrowing required to finance the GRSi acquisition.

Provision for Income Taxes

For the three months ended June 30, 2023 and 2022, DLH recorded a $0.4 million and $1.7 million provision for tax expense, respectively. The effective tax rate for the three months ended June 30, 2023 and 2022 was 23% and 26%, respectively.

Results of Operations for the Nine Months Ended June 30, 2023 and 2022

The following table summarizes, for the periods indicated, consolidated statements of operations data expressed in dollars in thousands except for per share amounts, and as a percentage of revenue:

	Nine Months Ended								Change
Consolidated Statements of  Operations:	June 30, 2023				June 30, 2022				$
Revenue	$	274,385	100.0	%	$	327,940	100.0	%	$	(53,555)
Cost of operations:
Contract costs	216,779		79.0	%	271,184		82.7	%	(54,405)
General and administrative costs	27,670		10.1	%	22,178		6.8	%	5,492
Corporate development costs	1,735		0.6	%	250		0.1	%	1,485
Depreciation and amortization	11,281		4.1	%	5,740		1.7	%	5,541
Total operating costs	257,465		93.8	%	299,352		91.3	%	(41,887)
Income from operations	16,920		6.2	%	28,588		8.7	%	(11,668)
Interest expense	11,512		4.2	%	1,739		0.5	%	9,773
Income before provision for income taxes	5,408		2.0	%	26,849		8.2	%	(21,441)
Income tax expense	1,318		0.5	%	7,003		2.1	%	(5,685)
Net income	$	4,090	1.5	%	$	19,846	6.1	%	$	(15,756)
Net income per share - basic	$	0.30			$	1.55			$	(1.25)
Net income per share - diluted	$	0.28			$	1.40			$	(1.12)

The following factors have affected our operating results for the nine months ended June 30, 2023 as compared to the same period in the 2022 fiscal year:

•During the quarter ended December 31, 2022, we acquired GRSi. From the date of this acquisition, we have received the benefit of additional revenue, as well as incurred additional operating costs. In addition, we amended and restated

28

our credit facility to fund the acquisition of GRSi and the cost of servicing this debt has resulted in an increase in our interest expense.

•Our results of operations for the nine months ended June 30, 2022 included revenues of approximately $125.8 million derived from the two task orders awarded under a FEMA contact to support the State of Alaska in its response to the COVID-19 pandemic. These task orders were completed during the quarter ended March 31, 2022 and there was no comparable revenue contribution from this work during the 2023 period.

Due to these developments, in the “Non-GAAP Financial Measures” section below, we have included a discussion of our adjusted financial performance to present our financial performance for the nine months ended June 30, 2023 and 2022 without the impacts of the FEMA task orders and including the corporate development costs associated with the GRSi acquisition.

Revenue

Revenue for the nine months ended June 30, 2023 was $274.4 million, a decrease of $53.6 million over the prior year period. The decrease in revenue is due primarily to the completion of two task orders awarded under a FEMA contract to support Alaska with its response to COVID-19. The revenue contribution from those task orders was $125.8 million. The decrease in revenue was partially offset by the contribution from GRSi of $73.9 million.

Cost of Operations

Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs. For the nine months ended June 30, 2023, contract costs decreased by approximately $54.4 million principally due to the completion of two task orders awarded under a FEMA contract to support Alaska with its response to COVID-19.

General and administrative costs are for those employees not directly providing services to our customers, to include but not limited to executive management, bid and proposal, accounting, and human resources. These costs increased by approximately $5.5 million from the same period in the prior fiscal year. The increase was principally due to the inclusion of GRSi.

For the nine months ended June 30, 2023, depreciation and amortization costs were approximately $0.6 million and $10.7 million, respectively, as compared to approximately $0.8 million and $4.9 million for the prior fiscal year period, respectively.

Interest Expense, net

Interest expense, net, includes interest expense on the Company's term loan and amortization of deferred financing costs on debt obligations. For the nine months ended June 30, 2023 and 2022, interest expense, net was approximately $11.5 million and $1.7 million, respectively. The increase in interest expense was primarily due to the borrowing required to finance the GRSi acquisition.

Income Tax Expense

For the nine months ended June 30, 2023 and 2022, DLH recorded a $1.3 million and $7.0 million provision for tax expense, respectively. The effective tax rate for the nine months ended June 30, 2023 and 2022 was 23% and 26%, respectively.

Non-GAAP Financial Measures

The Company uses EBITDA and EBITDA Margin on Revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA Margin on Revenue is EBITDA for the measurement period divided by revenue for the same period.

The Company is presenting additional non-GAAP measures regarding its financial performance for the three and nine months ended June 30, 2023. The measures presented are Adjusted Revenue, Adjusted Operating Income, Adjusted EBITDA, and Adjusted EBITDA Margin on Adjusted Revenue. In calculating these measures, we have added the corporate development costs associated with completing the GRSi acquisition to our results for fiscal year 2023 and we have removed the contribution

29

from the FEMA task orders from the results for fiscal year 2022. These resulting measures present the quarterly financial performance compared to results delivered in the prior year period. Definitions of these additional non-GAAP measures are set forth below.

We have prepared these additional non-GAAP measures to eliminate the impact of items that we do not consider indicative of ongoing operating performance due to their inherent unusual or extraordinary nature. These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.

These supplemental performance measurements may vary from and may not be comparable to similarly titled measures by other companies in our industry. Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Adjusted Revenue are not recognized measurements under accounting principles generally accepted in the United States, or GAAP, and when analyzing our performance investors should (i) evaluate each adjustment in our reconciliation to the nearest GAAP financial measures and (ii) use the aforementioned non-GAAP measures in addition to, and not as an alternative to, revenue, operating income, net income or diluted EPS, as measures of operating results, each as defined under GAAP. We have defined these non-GAAP measures as follows:

“Adjusted Revenue” represents revenue less the contribution to revenue from the short-term FEMA task orders

“Adjusted Operating Income” represents operating income plus the corporate development costs associated with completing the GRSi acquisition incurred in fiscal 2023 less the contribution from the FEMA task orders, which occurred in fiscal 2022.

“Adjusted EBITDA” represents net income before income taxes, interest, depreciation and amortization and the corporate costs associated with completing the acquisition, less the contribution from FEMA task orders. “Adjusted EBITDA Margin on Adjusted Revenue” is calculated as Adjusted EBITDA divided by Adjusted Revenue.

30

Below is a reconciliation of Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue and Adjusted EBITDA Margin on Adjusted Revenue reported for the three and nine months ended June 30, 2023 and 2022 compared to the most directly comparable financial measure calculated and presented in accordance with GAAP as follows (in thousands except for per share amounts):

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
	2023		2022		Change		2023		2022		Change
Adjusted Revenue
Revenue	$	102,241	$	66,440	$	35,801	$	274,385	$	327,940	$	(53,555)
Less: FEMA task orders to support Alaska (a)	—		(5,116)		5,116		—		125,773		(125,773)
Adjusted Revenue	$	102,241	$	71,556	$	30,685	$	274,385	$	202,167	$	72,218
Adjusted Operating Income
Operating Income	$	7,107	$	7,114	$	(7)	$	16,920	$	28,588	$	(11,668)
Corporate development costs (b)	—		—		—		1,735		—		1,735
Less: FEMA task orders to support Alaska (c)	—		608		(608)		—		12,479		(12,479)
Adjusted Operating Income	$	7,107	$	6,506	$	601	$	18,655	$	16,109	$	2,546
EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue & Adjusted EBITDA Margin on Adjusted Revenue
Net Income	$	1,738	$	4,864	$	(3,126)	$	4,090	$	19,846	$	(15,756)
Depreciation and amortization	4,280		1,873		2,407		11,281		5,740		5,541
Interest expense	4,917		512		4,405		11,512		1,739		9,773
Income tax expense	452		1,738		(1,286)		1,319		7,003		(5,684)
EBITDA	$	11,387	$	8,987	$	2,400	$	28,202	$	34,328	$	(6,126)
Corporate development costs (b)	—		$	—	—		1,735		—		1,735
Less: FEMA task order to support Alaska (c)	—		608		(608)		—		12,479		(12,479)
Adjusted EBITDA	$	11,387	$	8,379	$	3,008	$	29,937	$	21,849	$	8,088
Net income margin on Revenue	1.7%		7.3%				1.5%		6.1%
EBITDA Margin on Revenue	11.1%		13.5%				10.3%		10.5%
Adjusted EBITDA Margin on Adjusted Revenue	11.1%		11.7%				10.9%		10.8%

(a): Represents revenue adjusted to exclude revenue from the short-term FEMA task orders during the three and nine months ended June 30, 2022.

(b): Represents corporate development costs we incurred to complete the GRSi transaction. These costs primarily include legal counsel, financial due diligence, customer market analysis and representation and warranty insurance premiums.

(c): Adjusted operating income represents the Company’s consolidated operating income, determined in accordance with GAAP, adjusted to add the corporate development costs associated with the GRSi acquisition for fiscal year 2023 and adjusted to exclude the operating income derived from the FEMA task orders. Operating income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended June 30, 2022 of ($5.1) million contract costs of ($5.7) million . Similarly, for the nine months ended June 30, 2022 operating income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs $112.1 million and general & administrative costs of $1.2 million.

31

Liquidity and capital management

As of June 30, 2023, the Company's immediate sources of liquidity include cash generated from operations, accounts receivable, and access to its secured revolving line of credit facility. This credit facility provides us with access of up to $70.0 million, subject to certain conditions including eligible accounts receivable. As of June 30, 2023, we have $32.9 million of available borrowing capacity on the revolving line of credit and have an outstanding balance of $16.4 million.

The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. Deposits held with financial institutions may exceed the $250,000 limit. DLH has not experienced any loss or denied any access to funds as a result of holding amounts in our bank accounts in excess to the FDIC limit. Our current investment and financing obligations are adequately satisfied by cash generated from operations and through access to our credit facility. Cash provided by operating activities is expected to be sufficient to support the Company's capital requirements and debt reduction goals.

A summary of the change in cash is presented below for the nine months ended June 30, 2023 and 2022 as follows (in thousands):

	2023		2022
Net cash provided by (used in) operating activities	$	14,997	$	(4,759)
Net cash used in investing activities	(181,291)		(244)
Net cash provided by (used in) financing activities	166,596		(17,988)
Net change in cash	$	302	$	(22,991)

The cash used in investing activities was primarily due to the acquisition of GRSi and the purchase of capital assets purchased during the nine months ended June 30, 2023. Cash provided by financing activities was $166.6 million during the nine months ended June 30, 2023 and were deployed to finance the GRSi acquisition. We intend to continue using cash to make mandatory and voluntary debt prepayments in future quarters subject to available cash.

Sources of cash

As of June 30, 2023, our immediate sources of liquidity include cash of approximately $0.5 million, accounts receivable, and access to our secured revolving line of credit facility. This credit facility provides us with access of up to $70.0 million, subject to certain conditions including eligible accounts receivable. As of June 30, 2023, we had unused borrowing capacity of $32.9 million, which is net of outstanding letters of credit. The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations. We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements.

Credit Facilities

A summary of our credit facilities for the period ended June 30, 2023 is as follows (in millions):

Arrangement	Loan Balance		Interest*	Maturity Date
Secured term loan (a) due December 8, 2027	$	179.3	SOFR* + 4.2%	December 8, 2027
Secured revolving line of credit (b) due December 8, 2027	$	16.4	SOFR* + 4.2%	December 8, 2027

*SOFR as of June 30, 2023 was 5.2%

On September 30, 2019, we executed a floating-to-fixed interest rate swap with First National Bank ("FNB") as counter-party. The notional amount in the floating-to-fixed interest rate swap as of June 30, 2023 is $16.2 million matures in 2024, and the fixed rate is 1.61%. On January 31, 2023, we executed an additional floating-to-fixed interest rate swap with FNB; the notional amount as of June 30, 2023 is $96.0 million, it matures in January 2026, and the fixed rate is 4.1%. The total floating-to-fixed swap balance as of June 30, 2023 is $112.2 million.

32

(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027.

(b) The secured revolving line of credit has a ceiling of up to $70.0 million and a maturity date of December 8, 2027. The Company has accessed funds from the revolving credit facility during the quarter and has a balance outstanding at June 30, 2023 of $16.4 million

The secured term loan and secured revolving line of credit are secured by liens on substantially all of the assets of the Company. The provisions of our credit facilities are fully described in Note 8 to the consolidated financial statements.

Contractual Obligations as of June 30, 2023

			Payments Due by Period
			Next 12		2-3		4-5		More than 5
(in thousands)	Total		Months		Years		Years		Years
Debt obligations	$	195,760	$	14,250	$	36,813	$	144,697	$	—
Facility operating leases	24,636		3,501		7,963		5,668		7,504
Equipment operating leases	67		17		50		—		—
Total contractual obligations	$	220,463	$	17,768	$	44,826	$	150,365	$	7,504

Critical Accounting Policies and Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include valuation of goodwill and intangible assets, stock-based compensation, and measurement of loss development on workers' compensation claims. In addition, the Company estimates overhead charges and allocates such charges throughout the year. Actual results could differ from those estimates. For a detailed discussion on the application of these and other accounting policies, you should review the discussion under the caption Significant Accounting Policies in Note 2 of the notes to our consolidated financial statements contained elsewhere in this report.

Revenue Recognition

We recognize revenue over time when there is a continuous transfer of control to our customer. For our U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the U.S. government to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process. When control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. For services contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress.

For time and materials contracts, revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred. Revenue for cost reimbursable contracts is recorded as reimbursable costs are incurred, including an estimated share of the applicable contractual fees earned. For firm fixed price contracts, the consideration received for our performance is set at a predetermined price. Revenue for our firm fixed price contracts is recognized over time using a straight-line measure of progress. Contract costs are expensed as incurred. Estimated losses are recognized when identified.

Refer to Note 5 of the accompanying notes to our consolidated financial statements contained elsewhere in this report.

33

Long-lived Assets

Our long-lived assets include equipment and improvements, right-of-use assets, intangible assets, and goodwill. The Company continues to review its long-lived assets for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value.

Equipment and improvements are stated at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements.

Costs incurred to place the asset in service are capitalized and costs incurred after implementation are expensed. Amortization expense is recorded when the software is placed in service on a straight-line basis over the estimated useful life of the software.

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.

Intangible assets are originally recorded at fair value and amortized on a straight-line basis over their assessed useful lives. The assessed useful lives of the assets are 10 years.

Goodwill

The Company continues to review its goodwill for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Based on the results of the work performed, the Company has concluded that no impairment loss was warranted, as no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Our assessment incorporated effects of the COVID-19 pandemic, which did not have a meaningful impact on our financial results. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations.

Provision for Income Taxes

The Company accounts for income taxes in accordance with the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheet when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. The Company has fully utilized its net operating loss carryforwards.

Stock-based Equity Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to capital stock.

ITEM 3:         QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Except as described elsewhere in this report, the Company has not engaged in trading practices in securities or other financial instruments and therefore does not have any material exposure to interest rate risk, foreign currency exchange rate risk, commodity price risk or other similar risks, which might otherwise result from such practices. The Company has limited foreign operations and therefore is not materially subject to fluctuations in foreign exchange rates, commodity prices or other market rates or prices from market sensitive instruments. On September 30, 2019, we executed a floating-to-fixed interest rate swap

34

with FNB as counter-party. The notional amount in the floating-to-fixed interest rate swap is $16.2 million for the current quarter and the remaining outstanding balance of our secured term loan is subject to interest rate fluctuations. On January 31, 2023, we executed an additional floating-to-fixed interest rate swap with FNB; the notional amount as of June 30, 2023 is $96.0 million, it matures in January 2026, and the fixed rate is 4.1% The total notional amount for all the interest rate swaps is currently $112.2 million with the remaining balance of debt subject to floating interest rates.

We have determined that a 1.0% increase to SOFR would impact our interest expense by approximately $0.8 million per year. As of June 30, 2023, the interest rate on the floating interest rate debt was 9.3%.

ITEM 4:         CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our CEO and President and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on the evaluation of these controls and procedures, our disclosure controls and procedures were effective at the reasonable assurance level to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) that such information is accumulated and communicated to our management, including our CEO and President and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Our management, including our CEO and President and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. Our management, however, believes our disclosure controls and procedures are in fact effective to provide reasonable assurance that the objectives of the control system are met.

Changes in Internal Control over Financial Reporting

With the exception of the matter described below there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) identified in connection with the evaluation of our internal controls that occurred during the fiscal quarter ended June 30, 2023, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

In December 2022, we acquired Grove Resource Solutions, LLC and are in the process of integrating this business into our existing control environment.

PART II — OTHER INFORMATION 

ITEM 1:         LEGAL PROCEEDINGS

As a commercial enterprise and employer, the Company is subject to various claims and legal actions in the ordinary course of business. These matters can include professional liability, workers’ compensation, tax, payroll and employee-related matters, other commercial disputes arising in the course of its business, and inquiries and investigations by governmental agencies regarding our employment practices or other matters. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position or cash flows.

35

ITEM 1A:      RISK FACTORS

Our operating results and financial condition have varied in the past and may in the future vary significantly depending on a number of factors. In addition to the other information set forth in this report, you should carefully consider the factors discussed in the “Risk Factors” section in our Annual Report on Form 10-K for the year ended September 30, 2022, in our Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, and in our other reports filed with the SEC concerning the risks associated with our business, financial condition and results of operations. These factors, among others, could materially and adversely affect our business, results of operations, financial condition or liquidity and cause our actual results to differ materially from those contained in statements made in this report and presented elsewhere by management from time to time. The risks we have identified in our reports are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial may also materially adversely affect our business, results of operations, financial condition or liquidity. See Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022. We believe that there have been no material changes from the risk factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022 and our Quarterly Report on Form 10-Q for the quarter ended December 31, 2022.

ITEM 2:         UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the period covered by this report, the Company did not issue any securities that were not registered under the Securities Act of 1933, as amended, except as has been reported in previous filings with the SEC or as set forth elsewhere herein. 

ITEM 3:         DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4:         MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5:         OTHER INFORMATION

None.

36

ITEM 6:        EXHIBITS

Exhibits to this report which have previously been filed with the Commission are incorporated by reference to the document referenced in the following table. The exhibits designated with a number sign (#) indicate a management contract or compensation plan or arrangement.

Exhibit		Incorporated by Reference			Filed
Number	Exhibit Description	Form	Dated	Exhibit	Herewith
31.1	Certification of Chief Executive Officer pursuant to Section 17 CFR 240.13a-14(a) or 17 CFR 240.15d-14(a)				X
31.2	Certification of Chief Financial Officer pursuant to Section 17 CFR 240.13a-14(a) or 17 CFR 240.15d-14(a)				X
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 17 CFR 240.13a-14(b) or 17 CFR 240.15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code				X
101.0	The following financial information from the DLH Holdings Corp. Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language) and filed electronically herewith: (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Cash Flows; and, (iv) the Notes to the Consolidated Financial Statements.				X
104.0	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

37

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DLH HOLDINGS CORP.
	By:	/s/ Kathryn M. JohnBull
		Kathryn M. JohnBull
		Chief Financial Officer
		(On behalf of the Registrant and as Principal Financial and Accounting Officer)
Date: August 2, 2023

38

EX-31.1

EXHIBIT 31.1

Certification

I, Zachary C. Parker, certify that:

1	I have reviewed this quarterly report on Form 10-Q of DLH Holdings Corp.;
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4	The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a)		designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)		designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 2, 2023

/s/ Zachary C. Parker

Zachary C. Parker

Chief Executive Officer
(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

Certification

I, Kathryn M. JohnBull, certify that:

1	I have reviewed this quarterly report on Form 10-Q of DLH Holdings Corp.;
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4	The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 2, 2023

/s/ Kathryn M. JohnBull

Kathryn M. JohnBull

Chief Financial Officer
(Principal Accounting Officer)

EX-32.1

EXHIBIT 32

Certification of Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of DLH Holdings Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, being, Zachary C. Parker, Chief Executive Officer, and Kathryn M. JohnBull, Chief Financial Officer and Principal Accounting Officer, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: August 2, 2023

/s/ Zachary C. Parker	/s/ Kathryn M. JohnBull
Zachary C. Parker	Kathryn M. JohnBull
Chief Executive Officer (Principal Executive Officer)	Chief Financial Officer (Principal Accounting Officer)

     A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request..

XML

Cover - shares	9 Months Ended
	Jun. 30, 2023	Jul. 31, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	0-18492
Entity Registrant Name	DLH HOLDINGS CORP.
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	22-1899798
Entity Address, Address Line One	3565 Piedmont Road,
Entity Address, Address Line Two	Building 3,
Entity Address, Address Line Three	Suite 700
Entity Address, City or Town	Atlanta,
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30305
City Area Code	770
Local Phone Number	554-3545
Title of 12(b) Security	Common Stock
Trading Symbol	DLHC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		13,899,969
Entity Central Index Key	0000785557
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--09-30

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 102,241	$ 66,440	$ 274,385	$ 327,940
Contract costs	80,919	49,668	216,779	271,184
General and administrative costs	9,935	7,535	27,670	22,178
Corporate development costs	0	250	1,735	250
Depreciation and amortization	4,280	1,873	11,281	5,740
Operating Costs and Expenses	95,134	59,326	257,465	299,352
Income from operations	7,107	7,114	16,920	28,588
Interest expense	4,917	512	11,512	1,739
Income before provision for income taxes	2,190	6,602	5,408	26,849
Provision for income taxes	452	1,738	1,318	7,003
Net income	$ 1,738	$ 4,864	$ 4,090	$ 19,846
Net income per share - basic (in dollars per share)	$ 0.13	$ 0.38	$ 0.30	$ 1.55
Net income per share - diluted (in dollars per share)	$ 0.12	$ 0.34	$ 0.28	$ 1.40
Weighted average common stock outstanding
Basic (in shares)		12,812		12,779

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 530	$ 228
Accounts receivable	67,882	40,496
Other current assets	4,082	2,878
Total current assets	72,494	43,602
Equipment and improvements, net	1,690	1,704
Operating lease right-of-use assets	17,911	16,851
Goodwill	138,301	65,643
Intangible assets, net	128,891	40,884
Other long-term assets	88	328
Total assets	359,375	169,012
Debt obligations - current, net of deferred financing costs	28,716	0
Current liabilities:
Operating lease liabilities - current	3,478	2,235
Accrued payroll	17,545	9,444
Accounts payable and accrued liabilities	25,602	26,862
Total current liabilities	75,341	38,541
Deferred taxes, net	1,203	1,534
Operating lease liabilities - long-term	16,485	16,461
Debt obligations - long-term, net of deferred financing costs	159,379	20,416
Other long-term liabilities	1,801	0
Total long-term liabilities	178,868	38,411
Total liabilities	254,209	76,952
SHAREHOLDERS’ EQUITY
Common stock, $0.001 par value; 40,000 shares authorized; 13,900 and 13,047 shares issued and outstanding at June 30, 2023 and September 30, 2022, respectively	14	13
Additional paid-in capital	100,072	91,057
Retained earnings	5,080	990
Total shareholders’ equity	105,166	92,060
Total liabilities and shareholders' equity	$ 359,375	$ 169,012

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Sep. 30, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	40,000,000	40,000,000
Common stock, issued (in shares)	13,900,000	13,047,000
Common stock, outstanding (in shares)	13,900,000	13,047,000

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities
Net income	$ 4,090	$ 19,846
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	11,281	5,740
Amortization of deferred financing costs charged to interest expense	1,540	497
Stock-based compensation expense	2,020	1,952
Deferred Income Tax Expense (Benefit)	0	(1)
Changes in operating assets and liabilities
Increase (Decrease) in Accounts Receivable	(1,918)	(16,890)
Increase (Decrease) in Other Current Assets	130	(152)
Accrued payroll	274	4,032
Deferred revenue	0	(22,273)
Accounts payable and accrued liabilities	(4,221)	2,380
Other long-term assets and liabilities	1,801	110
Net cash provided by (used in) operating activities	14,997	(4,759)
Investing activities
Business acquisition, net of cash acquired	(180,711)	0
Purchase of equipment and improvements	(580)	(244)
Net cash used in investing activities	(181,291)	(244)
Financing activities
Proceeds from revolving line of credit	144,697	0
Repayment of revolving line of credit	(128,204)	0
Proceeds from debt obligations	168,000	13,500
Repayments of debt obligations	(10,688)	(31,750)
Payments of deferred financing costs	(7,666)	0
Proceeds from issuance of common stock upon exercise of options and warrants	1,107	543
Payment of tax obligations resulting from net exercise of stock options	(650)	(281)
Net cash provided by (used in) financing activities	166,596	(17,988)
Net change in cash	302	(22,991)
Cash - beginning of period	228	24,051
Cash - end of period	530	1,060
Supplemental disclosure of cash flow information
Cash paid during the period for interest	10,006	1,195
Cash paid during the period for income taxes	4,055	6,403
Common stock surrendered for the exercise of stock options	$ 238	$ 256

XML

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid-In Capital	Retained Earnings
Beginning Balance (in shares) at Sep. 30, 2021		12,714,000
Beginning balance at Sep. 30, 2021	$ 65,608,000	$ 13,000	$ 87,893,000	$ (22,298,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Expense related to director restricted stock units	486,000		486,000
Common stock surrendered for the exercise of stock options (in shares)		(31,000)
Common stock surrendered for the exercise of stock options	(281,000)		(281,000)
Exercise of stock options (in shares)		224,000
Exercise of stock options	343,000		343,000
Exercise of stock warrants (in shares)		54,000
Exercise of stock warrants	200,000		200,000
Net income	19,846,000			19,846,000
Ending Balance (in shares) at Jun. 30, 2022		12,961,000
Ending balance at Jun. 30, 2022	87,668,000	$ 13,000	90,107,000	(2,452,000)
Beginning Balance (in shares) at Mar. 31, 2022		12,794,000
Beginning balance at Mar. 31, 2022	82,361,000	$ 13,000	89,664,000	(7,316,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Expense related to director restricted stock units	162,000		162,000
Common stock surrendered for the exercise of stock options (in shares)		(31,000)
Common stock surrendered for the exercise of stock options	(281,000)		(281,000)
Exercise of stock options (in shares)		198,000
Exercise of stock options	81,000		81,000
Net income	4,864,000			4,864,000
Ending Balance (in shares) at Jun. 30, 2022		12,961,000
Ending balance at Jun. 30, 2022	$ 87,668,000	$ 13,000	90,107,000	(2,452,000)
Beginning Balance (in shares) at Sep. 30, 2022	13,047,000	13,047,000
Beginning balance at Sep. 30, 2022	$ 92,060,000	$ 13,000	91,057,000	990,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance and fair value adjustment of common stock in business combination (in shares)	527,000
Issuance and fair value adjustment of common stock in business combination	$ 6,539,000	$ 1,000	6,538,000
Expense related to director restricted stock units	539,000		539,000
Expense related to employee stock options	1,481,000		1,481,000
Common stock surrendered for the exercise of stock options (in shares)		(67,000)
Common stock surrendered for the exercise of stock options	$ (650,000)		(650,000)
Exercise of stock options (in shares)	393,000	393,000
Exercise of stock options	$ 1,107,000		1,107,000
Net income	$ 4,090,000			4,090,000
Ending Balance (in shares) at Jun. 30, 2023	13,900,000	13,900,000
Ending balance at Jun. 30, 2023	$ 105,166,000	$ 14,000	100,072,000	5,080,000
Beginning Balance (in shares) at Mar. 31, 2023		13,793,000
Beginning balance at Mar. 31, 2023	101,940,000	$ 14,000	98,584,000	3,342,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Expense related to director restricted stock units	179,000		179,000
Expense related to employee stock options	489,000		489,000
Exercise of stock options (in shares)		107,000
Exercise of stock options	820,000		820,000
Net income	$ 1,738,000			1,738,000
Ending Balance (in shares) at Jun. 30, 2023	13,900,000	13,900,000
Ending balance at Jun. 30, 2023	$ 105,166,000	$ 14,000	$ 100,072,000	$ 5,080,000

XML

Basis of Presentation and Principles of Consolidation

9 Months Ended

Jun. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The accompanying consolidated financial statements include the accounts of DLH Holdings Corp. and its wholly-owned subsidiaries (together with its subsidiaries, "DLH" or the "Company" and also referred to as "we," "us" and "our"). All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.

In management's opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the period ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending September 30, 2023 or any future period. Amounts as of and for the three and nine months ended June 30, 2023 and June 30, 2022 are unaudited. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2022 filed with the Securities and Exchange Commission on December 5, 2022.

XML

Significant Accounting Policies

9 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The most significant of these estimates and assumptions relate to estimating revenues and costs including overhead and its allocation, estimating progress toward the completion of performance obligations, assessing fair value of acquired assets and liabilities accounted for through business acquisitions, valuing and determining the amortization periods for long-lived intangible assets, interest rate swaps, stock-based compensation, right-of-use assets and leases liabilities, and loss development on workers' compensation claims. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current and expected future outcomes, third-party evaluations, and various other assumptions that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. We revise material accounting estimates if changes occur, such as more experience is acquired, additional information is obtained, or there is new information on which an estimate was or can be based. Actual results could differ from those estimates.

Revenue

The Company's revenues from contracts with customers are derived from offerings that include technology-enabled business process outsourcing, program management solutions, and public health research and analytics, substantially within the U.S. government and its agencies. The Company has various types of contracts including time-and-materials contracts, cost-reimbursable contracts, and firm-fixed-price contracts.

We consider a contract with a customer to exist when there is a commitment by both parties (customer and Company), payment terms are determinable, there is commercial substance, and collectability is probably in accordance with Accounting Standards Codification ("ASC") No. 606, Revenue from Contracts with Customers ("Topic 606").

We recognize revenue over time when there is a continuous transfer of control to our customer as performance obligations are satisfied. For our U.S. government contracts, this continuous transfer of control to the customer is transferred over time and revenue is recognized based on the extent of progress toward completion of the performance obligation. We consider control to transfer when we have a right to payment. In some instances, the Company commences providing services prior to formal approval to begin work from the customer. The Company considers these factors, the risks associated with commencing work, and legal enforceability in determining whether a contract exists under Topic 606.

Contract modification can occur throughout the life of the contract and can affect the transaction price, extend the period of performance, adjust funding, or create new performance obligations. We review each modification to assess the impact of these

contract changes to determine if it should be treated as part of the original performance obligation or as a separate contract. Contract modifications impact performance obligations when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price and our measure of progress for the performance obligation to which it relates is recognized as an adjustment to revenue and profit cumulatively. Furthermore, a significant change in one or more estimates could affect the profitability of our contracts. We recognize adjustments in estimated profit on contracts in the period identified.

For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress based on the contract type.

•Time and material - We bill the customer per labor hour and per material, and revenue is recognized in the amount invoiced as the amount corresponds directly to the value of our performance to date. Revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred.

•Cost reimbursable - We record reimbursable costs as incurred, including an estimated share of the contractual fee earned.

•Firm fixed price - We recognize revenue over time using a straight-line measure of progress

Contract costs generally include direct costs such as labor, materials, subcontract costs, and indirect costs identifiable with or allocable to a specific contract. Costs are expensed as incurred and include an estimate of the contractual fees earned. Contract costs incurred for U.S. government contracts, including indirect costs, are subject to audit and adjustment by various government audit agencies. Historically, our adjustments have not been material.

Contract assets - Amounts are invoiced as work progresses in accordance with agreed-upon contractual terms. In part, revenue recognition occurs before we have the right to bill, resulting in contract assets. These contract assets are reported within Accounts receivable, net on our consolidated balance sheets and are invoiced in accordance with payment terms defined in each contract. Period end balances will vary from period to period due to agreed-upon contractual terms.

Contract liabilities - Amounts are a result of billings in excess of costs incurred or prepayment for services to be rendered.

Fair Value of Financial Instruments

The carrying amounts of the Company's cash and cash equivalents, accounts receivable, contract assets, contract liabilities, accrued expenses, and accounts payable approximate fair value due to the short-term nature of these instruments. The fair values of the Company's debt instruments approximate fair value because the underlying interest rates approximate market rates that the Company could obtain for similar instruments at the balance sheet dates.

Long-lived Assets

Our long-lived assets include equipment and improvements, intangible assets, right-of-use assets, and goodwill. The Company continues to review long-lived assets for possible impairment or loss of value at least annually, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit's carrying amount is greater than its fair value.

Equipment and improvements are recorded at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Maintenance and repair costs are expensed as incurred. Intangible assets (other than goodwill) are originally recorded at fair value and are amortized on a straight-line basis over their estimated useful lives of 10 years. Maintenance and repair costs are expensed as incurred.

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs paid, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.

Lease Liabilities

The Company has leases for facilities and office equipment. Our lease liabilities are recognized as the present value of the future minimum lease payments over the lease term. Our lease payments consist of fixed and in-substance fixed amounts attributable to the use of the underlying asset over the lease term. Variable lease payments that do not depend on an index rate or are not in-substance fixed payments are excluded in the measurement of right-of-use assets and lease liabilities and are expensed in the period incurred. The incremental borrowing rate on our secured term loan is used in determining the present value of future minimum lease payments. Some of our lease agreements include options to extend the lease term or terminate the lease. These options are accounted for in our right-of-use assets and lease liabilities when it is reasonably certain that the Company will extend the lease term or terminate the lease. The Company does not have any finance leases.

Goodwill

The Company reviews goodwill for impairment on an annual basis and on a quarterly basis the Company assesses the impact of any macroeconomic changes that may impact the business conditions to determine if these changes have any adverse impact to goodwill. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. The Company determined that no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Provision for Income Taxes

The Company accounts for income taxes in accordance with the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheets when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. We account for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon the technical merits, it is more-likely-than-not that the position will be sustained upon examination. We had no uncertain tax positions at either June 30, 2023 or September 30, 2022. We report interest and penalties as a component of provision for income taxes. During the three and nine months ended June 30, 2023 and June 30, 2022, we recognized no interest and no penalties related to income taxes.

Stock-based Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock option or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to common stock.

Compensation expense for the portion of equity awards for which the requisite service has not been rendered is recognized as the requisite service is rendered. The compensation expense for that portion of awards has been based on the grant-date fair value of those awards as calculated for recognition purposes under applicable guidance. For options that vest based on the Company’s common stock achieving and maintaining defined market prices, the Company values the awards with a Monte Carlo method that utilizes various probability factors and other criterion in establishing fair value of the grant. The related compensation expense is recognized over the service period.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000.

Accounts Receivable

Receivables include amounts billed and currently due from customers where the right to consideration is unconditional and amounts unbilled. Both billed and unbilled amounts are non-interest bearing, unsecured, and recognized at an estimated realizable value that includes costs and fees, and are generally expected to be billed and received within a single year. We evaluate our receivables on a quarterly basis and determine whether an allowance is appropriate based on specific collection issues. No allowance for doubtful accounts was deemed necessary at either June 30, 2023 or September 30, 2022.

Earnings Per Share

Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common stock outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Treasury Stock

The Company periodically purchases its own common stock that is traded on public markets as part of announced stock repurchase programs. The repurchased common stock is classified as treasury stock on the consolidated balance sheets and held at cost. As of June 30, 2023 and September 30, 2022, the Company did not hold any treasury stock.

Preferred Stock

Our certificate of incorporation authorizes the issuance of "blank check" preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors up to an aggregate of 5,000,000 shares of preferred stock. As of June 30, 2023 and September 30, 2022, the Company has not issued any preferred stock.

Interest Rate Swap

The Company uses derivative financial instruments to manage interest rate risk associated with its variable debt. The Company's objective in using these interest rate derivatives is to manage its exposure to interest rate movements and reduce volatility of interest expense. The gains and losses due to changes in the fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt are recognized in interest expense in the consolidated statements of operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Risks & Uncertainties

Management evaluates the impact of global markets and economic factors on our industry and the potential for adverse effects on the Company's consolidated financial position and its operations. As of June 30, 2023, there was no indication of any global or economic impacts to our industry.

XML

New Accounting Pronouncements	9 Months Ended
	Jun. 30, 2023
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements In March 2020 and January 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and ASU No. 2021-01, “Reference Rate Reform (Topic 848): Scope,” respectively (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In December 2022, FASB issued ASU 2022-06 "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" which defers the end date for electing the relief provided in Topic 848 from December 31, 2022 to December 31, 2024. In the first quarter of fiscal 2023, the Company adopted the optional expedients and exceptions provided in Topic 848. The adoption did not have a material impact on the Company’s consolidated financial statements.

XML

Business Combination

9 Months Ended

Jun. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Business Combination

Business Combination

Acquisition of Grove Resource Solutions, LLC

On December 8, 2022, the Company acquired 100% of the equity interests of Grove Resource Solution, LLC ("GRSi") for a purchase price of $188.0 million, inclusive of the working capital adjustment completed and paid during this fiscal quarter. The acquisition was financed through a combination of:

•borrowings of $181.5 million under the Company’s amended and restated credit facility; and

•common stock issued of approximately 0.5 million shares, which were valued at $6.5 million in the aggregate, based on the shares issued to the previous owners as determined by the equity purchase agreement and the stock price on the acquisition date.

The acquisition of GRSi was consistent with the Company’s growth strategy, as it provided contract diversification, addition of key capabilities and increased presence in the military health market. The estimated goodwill derived from this transaction is primarily due to these attributes.

The Company has used the acquisition method of accounting for this transaction, whereby the assets acquired and liabilities assumed are recognized based upon their estimated fair values at the acquisition date.

The purchase price for GRSi was $188.0 million adjusted to reflect acquired cash, assumed liabilities and net working capital adjustments.

The Purchase Agreement contains customary representations, warranties and covenants by the parties. Subject to certain limitations and conditions, the seller and the equity holders of the seller do not have indemnity obligation for damages resulting from breaches or inaccuracies of the representations, warranties, and covenants of the seller, GRSI and the equity holders as set forth in the Purchase Agreement. The Purchase Agreement also provided for the establishment of an escrow account in order to satisfy (i) any downward adjustment of the purchase price base on GRSI's net working capital at the closing and (ii) certain specified indemnification obligations of the seller and equity holders that may arise following the closing. The escrow account is funded by an aggregate amount of approximately $4.3 million and the stock consideration. A representations and warranties insurance policy has been purchased by the Company in connection with the Purchase Agreement, under which the Company may seek recourse for breaches of the representations and warranties of the seller, GRSI and the equity holders. The representations and warranties insurance policy is subject to certain customary exclusions and a deductible.

In accordance with ASU 2017-01, the Company evaluated the transaction as an acquisition of a business. The Company has assessed the acquisition price to the fair value of the assets and liabilities of GRSi at the acquisition date. Based on the unaudited financial statements of GRSi on December 8, 2022, we accounted for the total acquisition consideration and allocation of fair value of the related assets and liabilities as follows (in thousands):

Purchase price for GRSi	$	187,997
Purchase price allocation:
Cash	747
Accounts receivable	25,468
Other current assets	1,354
Accounts payable and accrued expenses	(2,449)
Payroll liabilities	(7,826)
Other current liabilities	(325)
Equipment and improvements, net	463
Other long-term assets and liabilities	(781)
Intangible assets	98,688
Total identifiable net assets acquired	115,339
Goodwill	$	72,658

All operating units are aggregated into a single reportable segment. The acquisition of GRSi did not create an additional reportable segment as all operations report to a single Chief Operating Decision Maker (CODM), serve a similar customer base, and provide similar services within a common regulatory environment. The goodwill represents intellectual capital and the acquired workforce, of which both do not qualify as a separate intangible asset.

During the three months ended and nine months ended June 30, 2023, following the completion of the acquisition, GRSi contributed approximately $34.4 million and $73.9 million of revenue and $2.6 million and $4.1 million of income from operations, respectively.

The following table presents certain results for the three and nine months ended June 30, 2023 and 2022 as though the acquisition of GRSi had occurred on October 1, 2021. The unaudited pro forma information is presented for informational purposes only and is not necessarily indicative of our results if the acquisition had taken place on that date. The pro forma information was prepared by combining our reported historical results with the historical results of GRSi for the pre-acquisition periods. In addition, the reported historical amounts were adjusted for the following items, net of associated tax effects:

•The impact of recording GRSi's intangible asset amortization.

•The impact of interest expense for the new credit facility.

•The removal of legacy GRSi director's fees.

•The removal of transaction costs for the acquisition incurred by GRSi.

	(unaudited)				(unaudited)
	(in thousands)				(in thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
Pro forma results	2023		2022		2023		2022
Revenue	$	102,241	$	94,326	$	301,481	$	407,795
Net income	1,738		4,603		4,683		15,455
Number of shares outstanding - basic	13,854		12,812		13,638		12,779
Number of shares outstanding - diluted	14,539		14,235		14,421		14,205
Basic earnings per share	$0.13		$0.36		$0.34		$1.21
Diluted earnings per share	$0.12		$0.32		$0.32		$1.09

XML

Revenue Recognition

9 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition

The following table summarizes the contract balances recognized on the Company's consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Contract assets	$	19,300	$	7,682

Contract assets are included presented as part of the accounts receivables on the consolidated balances sheets. Contract liabilities are presented as deferred revenue, which had no balance as of June 30, 2023 and September 30, 2022.

Disaggregation of Revenue from Contracts with Customers

We disaggregate our revenue from contracts with customers by customer, contract type, as well as whether the Company acts as prime contractor or subcontractor. We believe these categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. The following series of tables present our revenue disaggregated by these categories:

Revenue by customer for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Department of Veterans Affairs	$	35,898	$	33,344	$	104,489	$	92,270
Department of Health and Human Services	44,536		27,741		115,528		78,452
Department of Defense	21,003		8,272		50,802		25,227
Department of Homeland Security	256		(4,908)		639		126,397
Other	548		1,991		2,927		5,594
Total	$	102,241	$	66,440	$	274,385	$	327,940

Revenue by contract type for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Time and Materials	$	51,572	$	44,672	$	154,366	$	263,072
Cost Reimbursable	29,110		11,979		58,951		34,364
Firm Fixed Price	21,559		9,789		61,068		30,504
Total	$	102,241	$	66,440	$	274,385	$	327,940

Revenue by whether the Company acts as a prime contractor or a subcontractor for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Prime Contractor	$	97,885	$	58,743	$	259,692	$	304,862
Subcontractor	4,356		7,697		14,693		23,078
Total	$	102,241	$	66,440	$	274,385	$	327,940

XML

Leases

9 Months Ended

Jun. 30, 2023

Leases [Abstract]

Leases

Leases

The following table summarizes lease balances presented on our consolidated balance sheets was as follows (in thousands):

	June 30,		September 30,
	2023		2022
Operating lease right-of-use assets	$	17,911	$	16,851
Operating lease liabilities, current	$	3,478	$	2,235
Operating lease liabilities - long-term	16,485		16,461
Total operating lease liabilities	$	19,963	$	18,696

As of June 30, 2023, operating leases for facilities and equipment have remaining lease terms of less than 1 to 7.9 years.

For the three and nine months ended June 30, 2023 and 2022, total lease costs for our operating leases was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Operating	$	1,097	$	869	$	2,921	$	2,684
Short-term	83		33		225		85
Variable	47		44		63		89
Sublease income (a)	(71)		(69)		(214)		(188)
Total lease costs	$	1,156	$	877	$	2,995	$	2,670

(a) The Company subleases a portion of one of its leased facilities. The sublease is classified as an operating lease with respect to the underlying asset. The sublease term is 5 years and includes two additional 1-year term extension options.

The Company's future minimum lease payments as of June 30, 2023 as follows (in thousands):

For the Fiscal Year Ending September 30,
2023 (remaining)	$	1,165
2024	4,611
2025	3,928
2026	3,700
2027	2,627
Thereafter	8,672
Total future lease payments	24,703
Less: imputed interest	(4,740)
Present value of future minimum lease payments	19,963
Less: current portion of operating lease liabilities	(3,478)
Long-term operating lease liabilities	$	16,485

At June 30, 2023, the weighted-average remaining lease term and weighted-average discount rate are 6.3 years and 6.4% respectively. The calculation of the weighted-average discount rate was determined based on borrowing terms from our secured term loan.

Other information related to our leases for the nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	2023	2022
Cash paid for amounts included in the measurement of lease liabilities	3,317	$	2,566
Lease liabilities arising from obtaining right-of-use assets	2,052	$	—

XML

Supporting Financial Information

9 Months Ended

Jun. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supporting Financial Information

Supporting Financial Information

Accounts receivable

The following table summarizes accounts receivable presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Billed receivables	$	48,582	$	32,814
Contract assets	19,300		7,682
Allowance for doubtful accounts	—		—
Accounts receivable	$	67,882	$	40,496

Other current assets

The following table summarizes other current assets presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Prepaid insurance and benefits	$	1,316	$	737
Prepaid licenses and other expenses	1,694		1,196
Other receivables	1,072		945
Other current assets	$	4,082	$	2,878

Equipment and improvements, net

The following table summarizes equipment and improvements, net presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Furniture and equipment	$	877	$	893
Computer equipment	5,328		2,316
Computer software	1,733		4,407
Leasehold improvements	1,878		1,614
Total equipment and improvements	9,816		9,230
Less: accumulated depreciation and amortization	(8,126)		(7,526)
Equipment and improvements, net	$	1,690	$	1,704

Depreciation and amortization expense was $0.2 million for each of the three months ended June 30, 2023 and 2022. Depreciation and amortization expense was $0.6 million and $0.8 million for the nine months ended June 30, 2023 and 2022, respectively.

Intangible assets

The following table summarizes intangible assets, net presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Intangible assets
Customer contracts and related customer relationships	$	113,622	$	47,044
Covenants not to compete	637		522
Trade name	13,034		3,051
Backlog	37,249		15,237
Total intangible assets	164,542		65,854
Less: accumulated amortization
Customer contracts and related customer relationships	(27,087)		(19,731)
Covenants not to compete	(362)		(316)
Trade name	(1,859)		(1,048)
Backlog	(6,343)		(3,875)
Total accumulated amortization	(35,651)		(24,970)
Intangible assets, net	$	128,891	$	40,884

Amortization expense was $4.1 million and $1.6 million for the three months ended June 30, 2023 and 2022, respectively. Amortization expense was $10.7 million and $4.9 million for the nine months ended June 30, 2023 and 2022, respectively.

As of June 30, 2023, the estimated amortization expense per fiscal year as follows (in thousands):

2023 (remaining)	$	4,096
2024	16,386
2025	16,385
2026	15,652
2027	14,624
Thereafter	61,748
Total amortization expense	$	128,891

Goodwill

The change in the carrying amount of goodwill as follows presented on our consolidated balance sheets as follows (in thousands):

Balance at September 30, 2022	$	65,643
Increase from GRSi acquisition (a)	72,658
Balance at June 30, 2023	$	138,301

Ref (a) ; The Company has completed its valuation assessment of the GRSi acquisition. Please refer to Note 4 for more information.

Accounts payable and accrued liabilities

The following table summarizes accounts payable and accrued liabilities presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Accounts payable	$	15,559	$	11,886
Accrued benefits	4,073		3,857
Accrued bonus and incentive compensation	3,147		3,625
Accrued workers' compensation insurance	2,749		4,880
Other accrued expenses	74		2,614
Accounts payable and accrued liabilities	$	25,602	$	26,862

Debt obligations

The following table summarizes debt obligations presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Secured revolving line of credit	$	16,448	$	—
Secured term loan	179,312		22,000
Less: unamortized deferred financing costs	(7,665)		(1,584)
Net bank debt obligations	188,095		20,416
Less: current portion of debt obligations, net of deferred financing costs (a)	(28,716)		—
Long-term portion of debt obligations, net of deferred financing costs	$	159,379	$	20,416

(a) Current portion comprises term loan amortization of $14.3 million and the $16.4 million outstanding balance on the secured revolving line of credit, net of $2.0 million of unamortized deferred financing costs.

Interest expense

The following table summarizes interest expense presented on our consolidated statements of operations for the three and nine months ended June 30, 2023 and 2022 as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Interest expense (a)	$	4,282	$	334	$	9,972	$	1,242
Amortization of deferred financing costs (b)	635		178		1,540		497
Interest expense	$	4,917	$	512	$	11,512	$	1,739

(a) Interest expense on borrowing.

(b) Amortization of expenses related to secured term loan and secured revolving line of credit.

XML

Credit Facilities

9 Months Ended

Jun. 30, 2023

Debt Disclosure [Abstract]

Credit Facilities

Credit FacilitiesA summary of our credit facilities as of June 30, 2023 and September 30, 2022 is as follows (in millions):

June 30, 2023				September 30, 2022
Arrangement	Loan Balance		Interest	Arrangement	Loan Balance		Interest
Secured term loan (a) due December 8, 2027	$	179.3	SOFR* + 4.2%	Secured term loan due September 30, 2025	$	22.0	LIBOR + 2.5%
Secured revolving line of credit (b) due December 8, 2027	$	16.4	SOFR* + 4.2%	Secured Revolving line of Credit due September 20, 2025	$	—	LIBOR + 2.5%

*Secured Overnight Financing Rate ("SOFR") as of June 30, 2023 was 5.2%.

On September 30, 2019, we executed a floating-to-fixed interest rate swap with First National Bank ("FNB") as counter-party. The notional amount in the floating-to-fixed interest rate swap as of June 30, 2023 is $16.2 million matures in 2024, and the fixed rate is 1.61%. On January 31, 2023, we executed an additional floating-to-fixed interest rate swap with FNB; the notional amount as of June 30, 2023 is $96.0 million, it matures in January 2026, and the fixed rate is 4.10% The total floating-to-fixed swap balance as of June 30, 2023 is $112.2 million. As a result of entering these agreements, for the nine months ended June 30, 2023, interest expense has been decreased by approximately $0.6 million.

(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027.

The Credit Agreement requires compliance with a number of financial covenants and contains restrictions on our ability to engage in certain transactions. Among other matters, we must comply with limitations on the following: granting liens; incurring other indebtedness; maintenance of assets; investments in other entities and extensions of credit; mergers and consolidations; and changes in nature of business. The loan agreement also requires us to comply with certain quarterly financial covenants including: (i) a minimum fixed charge coverage ratio of at least 1.25 to 1.00, and (ii) a total leverage ratio not exceeding the ratio of 4.50:1.0 to 2.00:1.0 through maturity. The total leverage ratio is calculated by dividing the Company's total interest-bearing debt by net income adjusted to exclude (i) interest and other expenses, (ii) provision for or benefit from income taxes, if any, (iii) depreciation and amortization, and (iv) non-cash charges, losses or expenses, including stock-based compensation, and (v) non-recurring charges, losses or expenses to include transaction and non-cash equity expense. We are in compliance with all loan covenants and restrictions.

We are required to pay quarterly amortization payments, which commenced in December 2022. The annual amortization amounts are $14.3 million each for fiscal years 2023 and 2024, $19.0 million each for fiscal years 2025 and 2026, and $23.8 million for fiscal year 2027, with the remaining unpaid loan balance due at maturity in December 2027. The quarterly payments are equal installments. The Company made a mandatory prepayment of $3.6 million during the quarter ended June 30, 2023 bringing the outstanding principal balance on the secured term loan to $179.3 million. We have satisfied mandatory principal amortization until June 30, 2023.

In addition to quarterly payments of the outstanding indebtedness, the loan agreement also requires annual payments of a percentage of excess cash flow, as defined in the loan agreement. The loan agreement states that an excess cash flow recapture payment must be made equal to (a) 75% of the excess cash flow for the immediately preceding fiscal year in which the total leverage ratio is greater than or equal to 2.50:1.0; (b) 50% of the excess cash flow for the immediately preceding fiscal year in which the total leverage ratio is less than 2.50:1.0 but greater than or equal to 1.5:1.0; or (c) 0% of the excess cash flow for the immediately preceding fiscal year in which the total leverage ratio is less than 1.5:1.0. In addition, the Company must make additional mandatory prepayment of amounts outstanding based on proceeds received from asset sales and sales of certain indebtedness. For additional information regarding the schedule of future payment obligations, please refer to Note 11. Commitments and Contingencies.

(b) The secured revolving line of credit has a ceiling of up to $70.0 million; as of June 30, 2023 we had unused borrowing capacity of $32.9 million, which is net of outstanding letters of credit. Borrowing on the line of credit is secured by liens on substantially all of the assets of the Company. The Company accessed funds from the revolving credit facility during the quarter and had an outstanding balance at June 30, 2023 of $16.4 million.

The Company's total borrowing availability, based on eligible accounts receivable at June 30, 2023, was $32.9 million. As part of the revolving credit facility, the lenders agreed to a sublimit of $10.0 million for letters of credit for the account of the Company, subject to applicable procedures.The revolving line of credit has a maturity date of December 8, 2027 and is subject to loan covenants as described above. The Company is fully compliant with those covenants.

XML

Related Party Transactions	9 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party TransactionsThe Company has determined that for the three and nine months ended June 30, 2023 and June 30, 2022 there were no significant related party transactions that have occurred which require disclosure through the date that these consolidated financial statements were issued.

XML

Stock-based Compensation and Equity Grants

9 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Stock-based Compensation and Equity Grants

Stock-Based Compensation and Equity Grants

Stock-based compensation expense

Options issued under equity incentive plans were designated as either incentive stock or non-statutory stock options. No option is granted with a term of more than 10 years from the date of grant. Exercisability of option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued shares. As of June 30, 2023, there were 0.9 million shares available for grant under the 2016 Omnibus Equity Incentive Plan.

Stock-based compensation expense, shown in the table below, is recorded in general and administrative expenses included in our consolidated statements of operations for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	(in thousands)				(in thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
DLH employees (a)	$	489	$	481	$	1,481	$	1,466
Non-employee directors (b)	179		162		539		486
Total stock option expense	$	668	$	643	$	2,020	$	1,952

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, and stock option grants to employees during prior fiscal years. The RSUs totaled 337,578 and 161,485 issued and outstanding at June 30, 2023 and 2022, respectively. During the nine months ended June 30, 2023, 197,174 RSUs were granted to Executive Officers. Of the RSUs granted, 141,892 have performance-based vesting criteria and the remaining 55,282 have service-based vesting criteria. Utilizing a volatility of 50% along with assumptions of a 3-year term and the performance vesting criteria results in an indicated range of value, the RSUs granted during nine months ended June 30, 2023, as follows using the Monte Carlo Method.

				Volatility
				50%
				Calculated
Grant Date	Performance Vesting Base	Performance Vesting Criteria	(Years)	Fair Value
January 27, 2023	Revenue	Revenue increase at the end of the performance period as compared to the year ended September 30, 2022	3	$	3.51
January 27, 2023	Stock price	Stock price is at least $33.21 per share average for the 30 days prior to the end of the performance period	3	$	2.92
Notes:
Results based on 100,000 simulations

(b) Equity grants of RSUs were made in accordance with DLH compensation policy for non-employee directors and a total of 50,367 and 53,510 restricted stock units were issued and outstanding at June 30, 2023 and 2022, respectively. These grants have service-based vesting criteria and vest at the end of this fiscal year.

Unrecognized stock-based compensation expense

Unrecognized stock-based compensation expense is presented in the table below for the three months ended June 30, 2023 and 2022 as follows (in thousands):

	2023		2022
Unrecognized expense for DLH employees (a)	$	7,358	$	5,498
Unrecognized expense for non-employee directors	155		162
Total unrecognized expense	$	7,513	$	5,660

(a) On a weighted average basis, the unrecognized expense for the three months ended June 30, 2023 is expected to be recognized within the next 4.1 years.

Stock option activity for the nine months ended June 30, 2023

The aggregate intrinsic value in the table below represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their in the money options on those dates. This amount will change based on the fair market value of the Company’s stock.

				(in years)
				Weighted
		Weighted		Average	(in thousands)
	(in thousands)	Average		Remaining	Aggregate
	Number of	Exercise		Contractual	Intrinsic
	Shares	Price		Term	Value
Options outstanding, September 30, 2022	2,392	$	7.05	5.40	$	13,566
Granted (a)	400	11.66		—	—
Exercised (b)	(393)	3.42		—	—
Cancelled	(158)	9.07		—	—
Options outstanding, June 30, 2023	2,241	$	8.36	5.92	$	6,499

Ref (a): Utilizing a volatility of 50% along with assumptions of a 10-year term and the aforementioned 10-day stock price threshold results in an indicated range of value of the Options granted during three months ended March 31, 2023, as follows using the Monte Carlo Method.

								Volatility
								50%
					Vesting		Expected
	Strike		Stock		Threshold		Term	Calculated
Grant Date	Price		Price		Price		(Years)	Fair Value
January 26, 2023	$	11.66	$	11.66	$	15.00	10	$	7.41
Notes:
Results based on 100,000 simulations

Ref (b): The intrinsic value of options exercised for the three and nine months ended June 30, 2023 were $0.2 million and $3.4 million.

Stock options shares outstanding, vested and unvested for the periods ended as follows (shares in thousands):

	June 30,	September 30,
	2023	2022
Vested and exercisable (a)	1,616	2,117
Unvested (b)	625	275
Options outstanding	2,241	2,392

(a) The weighted average exercise price of vested and exercisable shares was $6.45 and $5.86 at June 30, 2023 and September 30, 2022, respectively. Aggregate intrinsic value was approximately $6.5 million and $13.6 million at June 30, 2023 and September 30, 2022, respectively. The weighted average contractual term remaining was 4.6 years and 4.9 years at June 30, 2023 and September 30, 2022, respectively.

(b) Certain awards vest upon satisfaction of certain performance criteria.

XML

Earnings Per Share

9 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common shares outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Earnings per share information is presented in the table below for the three and nine months ended June 30, 2023 and 2022 as follows (in thousands except for per share amounts):

	(In thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Numerator:
Net income	$	1,738	$	4,864	$	4,090	$	19,846
Denominator:
Denominator for basic net income per share - weighted-average outstanding shares	13,854		12,812		13,638		12,779
Effect of dilutive securities:
Stock options and restricted stock	685		1,423		783		1,426
Denominator for diluted net income per share - weighted-average outstanding shares	14,539		14,235		14,421		14,205
Net income per share - basic	$	0.13	$	0.38	$	0.30	$	1.55
Net income per share - diluted	$	0.12	$	0.34	$	0.28	$	1.40

XML

Commitment and Contingencies

9 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Contractual obligations as of June 30, 2023 are as follows (in thousands):

			Payments Due Per Fiscal Year
			(Remaining)
	Total		2023		2024		2025		2026		2027		Thereafter
Debt obligations	$	195,760	$	3,563	$	14,250	$	19,000	$	19,000	$	23,750	$	116,197
Facility operating leases	24,636		1,148		4,561		3,928		3,700		2,627		8,672
Equipment operating leases	67		17		50		—		—		—		—
Total contractual obligations	$	220,463	$	4,728	$	18,861	$	22,928	$	22,700	$	26,377	$	124,869

Workers' Compensation

We accrue workers' compensation expense based on claims submitted, applying actuarial loss development factors to estimate the costs incurred but not yet recorded. Our accrued liability for claims development as of June 30, 2023 and September 30, 2022 was $2.7 million and $4.9 million, respectively.

Legal Proceedings

As a commercial enterprise and employer, the Company is subject to various claims and legal actions in the ordinary course of business. These matters can include professional liability, workers’ compensation, tax, payroll and employee-related matters, other commercial disputes arising in the course of its business, and inquiries and investigations by governmental agencies

regarding our employment practices or other matters. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position, or cash flows.

XML

Significant Accounting Policies (Policies)

9 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The most significant of these estimates and assumptions relate to estimating revenues and costs including overhead and its allocation, estimating progress toward the completion of performance obligations, assessing fair value of acquired assets and liabilities accounted for through business acquisitions, valuing and determining the amortization periods for long-lived intangible assets, interest rate swaps, stock-based compensation, right-of-use assets and leases liabilities, and loss development on workers' compensation claims. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current and expected future outcomes, third-party evaluations, and various other assumptions that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. We revise material accounting estimates if changes occur, such as more experience is acquired, additional information is obtained, or there is new information on which an estimate was or can be based. Actual results could differ from those estimates.

Revenue

The Company's revenues from contracts with customers are derived from offerings that include technology-enabled business process outsourcing, program management solutions, and public health research and analytics, substantially within the U.S. government and its agencies. The Company has various types of contracts including time-and-materials contracts, cost-reimbursable contracts, and firm-fixed-price contracts.

We consider a contract with a customer to exist when there is a commitment by both parties (customer and Company), payment terms are determinable, there is commercial substance, and collectability is probably in accordance with Accounting Standards Codification ("ASC") No. 606, Revenue from Contracts with Customers ("Topic 606").

We recognize revenue over time when there is a continuous transfer of control to our customer as performance obligations are satisfied. For our U.S. government contracts, this continuous transfer of control to the customer is transferred over time and revenue is recognized based on the extent of progress toward completion of the performance obligation. We consider control to transfer when we have a right to payment. In some instances, the Company commences providing services prior to formal approval to begin work from the customer. The Company considers these factors, the risks associated with commencing work, and legal enforceability in determining whether a contract exists under Topic 606.

Contract modification can occur throughout the life of the contract and can affect the transaction price, extend the period of performance, adjust funding, or create new performance obligations. We review each modification to assess the impact of these

contract changes to determine if it should be treated as part of the original performance obligation or as a separate contract. Contract modifications impact performance obligations when the modification either creates new or changes the existing enforceable rights and obligations. The effect of a contract modification on the transaction price and our measure of progress for the performance obligation to which it relates is recognized as an adjustment to revenue and profit cumulatively. Furthermore, a significant change in one or more estimates could affect the profitability of our contracts. We recognize adjustments in estimated profit on contracts in the period identified.

For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress based on the contract type.

•Time and material - We bill the customer per labor hour and per material, and revenue is recognized in the amount invoiced as the amount corresponds directly to the value of our performance to date. Revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred.

•Cost reimbursable - We record reimbursable costs as incurred, including an estimated share of the contractual fee earned.

•Firm fixed price - We recognize revenue over time using a straight-line measure of progress

Contract costs generally include direct costs such as labor, materials, subcontract costs, and indirect costs identifiable with or allocable to a specific contract. Costs are expensed as incurred and include an estimate of the contractual fees earned. Contract costs incurred for U.S. government contracts, including indirect costs, are subject to audit and adjustment by various government audit agencies. Historically, our adjustments have not been material.

Contract assets - Amounts are invoiced as work progresses in accordance with agreed-upon contractual terms. In part, revenue recognition occurs before we have the right to bill, resulting in contract assets. These contract assets are reported within Accounts receivable, net on our consolidated balance sheets and are invoiced in accordance with payment terms defined in each contract. Period end balances will vary from period to period due to agreed-upon contractual terms.

Contract liabilities - Amounts are a result of billings in excess of costs incurred or prepayment for services to be rendered.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying amounts of the Company's cash and cash equivalents, accounts receivable, contract assets, contract liabilities, accrued expenses, and accounts payable approximate fair value due to the short-term nature of these instruments. The fair values of the Company's debt instruments approximate fair value because the underlying interest rates approximate market rates that the Company could obtain for similar instruments at the balance sheet dates.

Long-Lived Assets

Long-lived Assets

Our long-lived assets include equipment and improvements, intangible assets, right-of-use assets, and goodwill. The Company continues to review long-lived assets for possible impairment or loss of value at least annually, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit's carrying amount is greater than its fair value.

Equipment and improvements are recorded at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Maintenance and repair costs are expensed as incurred. Intangible assets (other than goodwill) are originally recorded at fair value and are amortized on a straight-line basis over their estimated useful lives of 10 years. Maintenance and repair costs are expensed as incurred.

Leases

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs paid, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.

Lease Liabilities

The Company has leases for facilities and office equipment. Our lease liabilities are recognized as the present value of the future minimum lease payments over the lease term. Our lease payments consist of fixed and in-substance fixed amounts attributable to the use of the underlying asset over the lease term. Variable lease payments that do not depend on an index rate or are not in-substance fixed payments are excluded in the measurement of right-of-use assets and lease liabilities and are expensed in the period incurred. The incremental borrowing rate on our secured term loan is used in determining the present value of future minimum lease payments. Some of our lease agreements include options to extend the lease term or terminate the lease. These options are accounted for in our right-of-use assets and lease liabilities when it is reasonably certain that the Company will extend the lease term or terminate the lease. The Company does not have any finance leases.

Goodwill

Goodwill

The Company reviews goodwill for impairment on an annual basis and on a quarterly basis the Company assesses the impact of any macroeconomic changes that may impact the business conditions to determine if these changes have any adverse impact to goodwill. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. The Company determined that no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Provision for Income Taxes

Provision for Income TaxesThe Company accounts for income taxes in accordance with the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheets when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. We account for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon the technical merits, it is more-likely-than-not that the position will be sustained upon examination.

Stock-based Compensation

Stock-based Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock option or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to common stock.

Compensation expense for the portion of equity awards for which the requisite service has not been rendered is recognized as the requisite service is rendered. The compensation expense for that portion of awards has been based on the grant-date fair value of those awards as calculated for recognition purposes under applicable guidance. For options that vest based on the Company’s common stock achieving and maintaining defined market prices, the Company values the awards with a Monte Carlo method that utilizes various probability factors and other criterion in establishing fair value of the grant. The related compensation expense is recognized over the service period.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000.

Accounts Receivable

Receivables include amounts billed and currently due from customers where the right to consideration is unconditional and amounts unbilled. Both billed and unbilled amounts are non-interest bearing, unsecured, and recognized at an estimated realizable value that includes costs and fees, and are generally expected to be billed and received within a single year. We evaluate our receivables on a quarterly basis and determine whether an allowance is appropriate based on specific collection issues. No allowance for doubtful accounts was deemed necessary at either June 30, 2023 or September 30, 2022.

Earnings Per Share

Earnings Per ShareBasic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of common stock outstanding and restricted stock grants that vested or are likely to vest during the period. Diluted earnings per share is calculated by dividing income available to common shareholders by the weighted average number of basic common shares outstanding, adjusted to reflect potentially dilutive securities. Diluted earnings per share is calculated using the treasury stock method.

Treasury Stock and Preferred Stock

Treasury Stock

The Company periodically purchases its own common stock that is traded on public markets as part of announced stock repurchase programs. The repurchased common stock is classified as treasury stock on the consolidated balance sheets and held at cost. As of June 30, 2023 and September 30, 2022, the Company did not hold any treasury stock.

Preferred Stock

Our certificate of incorporation authorizes the issuance of "blank check" preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors up to an aggregate of 5,000,000 shares of preferred stock.

Interest Rate Swap

Interest Rate Swap

The Company uses derivative financial instruments to manage interest rate risk associated with its variable debt. The Company's objective in using these interest rate derivatives is to manage its exposure to interest rate movements and reduce volatility of interest expense. The gains and losses due to changes in the fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt are recognized in interest expense in the consolidated statements of operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Revenue Recognition

Disaggregation of Revenue from Contracts with Customers We disaggregate our revenue from contracts with customers by customer, contract type, as well as whether the Company acts as prime contractor or subcontractor. We believe these categories best depict how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors.

New Accounting Pronouncements

New Accounting Pronouncements In March 2020 and January 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and ASU No. 2021-01, “Reference Rate Reform (Topic 848): Scope,” respectively (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In December 2022, FASB issued ASU 2022-06 "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" which defers the end date for electing the relief provided in Topic 848 from December 31, 2022 to December 31, 2024. In the first quarter of fiscal 2023, the Company adopted the optional expedients and exceptions provided in Topic 848. The adoption did not have a material impact on the Company’s consolidated financial statements.

XML

Business Combinations (Tables)

9 Months Ended

Jun. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of Total Consideration and Preliminary Fair Value of Assets and Liabilities

Based on the unaudited financial statements of GRSi on December 8, 2022, we accounted for the total acquisition consideration and allocation of fair value of the related assets and liabilities as follows (in thousands):

Purchase price for GRSi	$	187,997
Purchase price allocation:
Cash	747
Accounts receivable	25,468
Other current assets	1,354
Accounts payable and accrued expenses	(2,449)
Payroll liabilities	(7,826)
Other current liabilities	(325)
Equipment and improvements, net	463
Other long-term assets and liabilities	(781)
Intangible assets	98,688
Total identifiable net assets acquired	115,339
Goodwill	$	72,658

Schedule of Pro Forma Information

In addition, the reported historical amounts were adjusted for the following items, net of associated tax effects:

•The impact of recording GRSi's intangible asset amortization.

•The impact of interest expense for the new credit facility.

•The removal of legacy GRSi director's fees.

•The removal of transaction costs for the acquisition incurred by GRSi.

	(unaudited)				(unaudited)
	(in thousands)				(in thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
Pro forma results	2023		2022		2023		2022
Revenue	$	102,241	$	94,326	$	301,481	$	407,795
Net income	1,738		4,603		4,683		15,455
Number of shares outstanding - basic	13,854		12,812		13,638		12,779
Number of shares outstanding - diluted	14,539		14,235		14,421		14,205
Basic earnings per share	$0.13		$0.36		$0.34		$1.21
Diluted earnings per share	$0.12		$0.32		$0.32		$1.09

XML

Revenue Recognition (Tables)

9 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Contract Balances Recognized on the Company's Consolidated Balance Sheets

The following table summarizes the contract balances recognized on the Company's consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Contract assets	$	19,300	$	7,682

Schedule of Disaggregation of Revenue From Contracts with Customers

The following series of tables present our revenue disaggregated by these categories:

Revenue by customer for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Department of Veterans Affairs	$	35,898	$	33,344	$	104,489	$	92,270
Department of Health and Human Services	44,536		27,741		115,528		78,452
Department of Defense	21,003		8,272		50,802		25,227
Department of Homeland Security	256		(4,908)		639		126,397
Other	548		1,991		2,927		5,594
Total	$	102,241	$	66,440	$	274,385	$	327,940

Revenue by contract type for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Time and Materials	$	51,572	$	44,672	$	154,366	$	263,072
Cost Reimbursable	29,110		11,979		58,951		34,364
Firm Fixed Price	21,559		9,789		61,068		30,504
Total	$	102,241	$	66,440	$	274,385	$	327,940

Revenue by whether the Company acts as a prime contractor or a subcontractor for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Prime Contractor	$	97,885	$	58,743	$	259,692	$	304,862
Subcontractor	4,356		7,697		14,693		23,078
Total	$	102,241	$	66,440	$	274,385	$	327,940

XML

Leases (Tables)

9 Months Ended

Jun. 30, 2023

Leases [Abstract]

Schedule of Summarized Lease Balances in Consolidated Balance Sheet

The following table summarizes lease balances presented on our consolidated balance sheets was as follows (in thousands):

	June 30,		September 30,
	2023		2022
Operating lease right-of-use assets	$	17,911	$	16,851
Operating lease liabilities, current	$	3,478	$	2,235
Operating lease liabilities - long-term	16,485		16,461
Total operating lease liabilities	$	19,963	$	18,696

Schedule of Lease Costs and Other Information Related to Leases

For the three and nine months ended June 30, 2023 and 2022, total lease costs for our operating leases was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Operating	$	1,097	$	869	$	2,921	$	2,684
Short-term	83		33		225		85
Variable	47		44		63		89
Sublease income (a)	(71)		(69)		(214)		(188)
Total lease costs	$	1,156	$	877	$	2,995	$	2,670

Other information related to our leases for the nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	2023	2022
Cash paid for amounts included in the measurement of lease liabilities	3,317	$	2,566
Lease liabilities arising from obtaining right-of-use assets	2,052	$	—

Schedule of Company's Future Lease Payments

The Company's future minimum lease payments as of June 30, 2023 as follows (in thousands):

For the Fiscal Year Ending September 30,
2023 (remaining)	$	1,165
2024	4,611
2025	3,928
2026	3,700
2027	2,627
Thereafter	8,672
Total future lease payments	24,703
Less: imputed interest	(4,740)
Present value of future minimum lease payments	19,963
Less: current portion of operating lease liabilities	(3,478)
Long-term operating lease liabilities	$	16,485

XML

Supporting Financial Information (Tables)

9 Months Ended

Jun. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Accounts Receivable

Accounts receivable

The following table summarizes accounts receivable presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Billed receivables	$	48,582	$	32,814
Contract assets	19,300		7,682
Allowance for doubtful accounts	—		—
Accounts receivable	$	67,882	$	40,496

Schedule of Other Current Assets

Other current assets

The following table summarizes other current assets presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Prepaid insurance and benefits	$	1,316	$	737
Prepaid licenses and other expenses	1,694		1,196
Other receivables	1,072		945
Other current assets	$	4,082	$	2,878

Schedule of Equipment and Improvements, Net

Equipment and improvements, net

The following table summarizes equipment and improvements, net presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Furniture and equipment	$	877	$	893
Computer equipment	5,328		2,316
Computer software	1,733		4,407
Leasehold improvements	1,878		1,614
Total equipment and improvements	9,816		9,230
Less: accumulated depreciation and amortization	(8,126)		(7,526)
Equipment and improvements, net	$	1,690	$	1,704

Schedule of Intangible Assets

Intangible assets

The following table summarizes intangible assets, net presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Intangible assets
Customer contracts and related customer relationships	$	113,622	$	47,044
Covenants not to compete	637		522
Trade name	13,034		3,051
Backlog	37,249		15,237
Total intangible assets	164,542		65,854
Less: accumulated amortization
Customer contracts and related customer relationships	(27,087)		(19,731)
Covenants not to compete	(362)		(316)
Trade name	(1,859)		(1,048)
Backlog	(6,343)		(3,875)
Total accumulated amortization	(35,651)		(24,970)
Intangible assets, net	$	128,891	$	40,884

Schedule of Estimated Amortization of Intangible Assets

As of June 30, 2023, the estimated amortization expense per fiscal year as follows (in thousands):

2023 (remaining)	$	4,096
2024	16,386
2025	16,385
2026	15,652
2027	14,624
Thereafter	61,748
Total amortization expense	$	128,891

Schedule of Accounts Payable, Accrued Expenses, and Other Current Liabilities

Accounts payable and accrued liabilities

The following table summarizes accounts payable and accrued liabilities presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Accounts payable	$	15,559	$	11,886
Accrued benefits	4,073		3,857
Accrued bonus and incentive compensation	3,147		3,625
Accrued workers' compensation insurance	2,749		4,880
Other accrued expenses	74		2,614
Accounts payable and accrued liabilities	$	25,602	$	26,862

Schedule of Debt Obligations

Debt obligations

The following table summarizes debt obligations presented on our consolidated balance sheets as follows (in thousands):

	June 30,		September 30,
	2023		2022
Secured revolving line of credit	$	16,448	$	—
Secured term loan	179,312		22,000
Less: unamortized deferred financing costs	(7,665)		(1,584)
Net bank debt obligations	188,095		20,416
Less: current portion of debt obligations, net of deferred financing costs (a)	(28,716)		—
Long-term portion of debt obligations, net of deferred financing costs	$	159,379	$	20,416

(a) Current portion comprises term loan amortization of $14.3 million and the $16.4 million outstanding balance on the secured revolving line of credit, net of $2.0 million of unamortized deferred financing costs.

Schedule of Interest Expense

Interest expense

The following table summarizes interest expense presented on our consolidated statements of operations for the three and nine months ended June 30, 2023 and 2022 as follows (in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Interest expense (a)	$	4,282	$	334	$	9,972	$	1,242
Amortization of deferred financing costs (b)	635		178		1,540		497
Interest expense	$	4,917	$	512	$	11,512	$	1,739

(a) Interest expense on borrowing.

(b) Amortization of expenses related to secured term loan and secured revolving line of credit.

Schedule of Changes in Carrying Amount of Goodwill

Goodwill

The change in the carrying amount of goodwill as follows presented on our consolidated balance sheets as follows (in thousands):

Balance at September 30, 2022	$	65,643
Increase from GRSi acquisition (a)	72,658
Balance at June 30, 2023	$	138,301

Ref (a) ; The Company has completed its valuation assessment of the GRSi acquisition. Please refer to Note 4 for more information.

XML

Credit Facilities (Tables)

9 Months Ended

Jun. 30, 2023

Debt Disclosure [Abstract]

Schedule of Loan Facility

A summary of our credit facilities as of June 30, 2023 and September 30, 2022 is as follows (in millions):

June 30, 2023				September 30, 2022
Arrangement	Loan Balance		Interest	Arrangement	Loan Balance		Interest
Secured term loan (a) due December 8, 2027	$	179.3	SOFR* + 4.2%	Secured term loan due September 30, 2025	$	22.0	LIBOR + 2.5%
Secured revolving line of credit (b) due December 8, 2027	$	16.4	SOFR* + 4.2%	Secured Revolving line of Credit due September 20, 2025	$	—	LIBOR + 2.5%

*Secured Overnight Financing Rate ("SOFR") as of June 30, 2023 was 5.2%.

XML

Stock-based Compensation and Equity Grants (Tables)

9 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense, shown in the table below, is recorded in general and administrative expenses included in our consolidated statements of operations for the three and nine months ended June 30, 2023 and 2022 was as follows (in thousands):

	(in thousands)				(in thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
DLH employees (a)	$	489	$	481	$	1,481	$	1,466
Non-employee directors (b)	179		162		539		486
Total stock option expense	$	668	$	643	$	2,020	$	1,952

(a) Included in this amount are equity grants of restricted stock units ("RSU") to Executive Officers, which were issued in accordance with the DLH long-term incentive compensation policy in this fiscal year, and stock option grants to employees during prior fiscal years. The RSUs totaled 337,578 and 161,485 issued and outstanding at June 30, 2023 and 2022, respectively. During the nine months ended June 30, 2023, 197,174 RSUs were granted to Executive Officers. Of the RSUs granted, 141,892 have performance-based vesting criteria and the remaining 55,282 have service-based vesting criteria. Utilizing a volatility of 50% along with assumptions of a 3-year term and the performance vesting criteria results in an indicated range of value, the RSUs granted during nine months ended June 30, 2023, as follows using the Monte Carlo Method.

Unrecognized stock-based compensation expense is presented in the table below for the three months ended June 30, 2023 and 2022 as follows (in thousands):

	2023		2022
Unrecognized expense for DLH employees (a)	$	7,358	$	5,498
Unrecognized expense for non-employee directors	155		162
Total unrecognized expense	$	7,513	$	5,660

(a) On a weighted average basis, the unrecognized expense for the three months ended June 30, 2023 is expected to be recognized within the next 4.1 years.

Schedule of Stock Option Activity

The aggregate intrinsic value in the table below represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their in the money options on those dates. This amount will change based on the fair market value of the Company’s stock.

				(in years)
				Weighted
		Weighted		Average	(in thousands)
	(in thousands)	Average		Remaining	Aggregate
	Number of	Exercise		Contractual	Intrinsic
	Shares	Price		Term	Value
Options outstanding, September 30, 2022	2,392	$	7.05	5.40	$	13,566
Granted (a)	400	11.66		—	—
Exercised (b)	(393)	3.42		—	—
Cancelled	(158)	9.07		—	—
Options outstanding, June 30, 2023	2,241	$	8.36	5.92	$	6,499

Ref (a): Utilizing a volatility of 50% along with assumptions of a 10-year term and the aforementioned 10-day stock price threshold results in an indicated range of value of the Options granted during three months ended March 31, 2023, as follows using the Monte Carlo Method.

Schedule of Option Shares Outstanding, Vested and Expected to Vest

Stock options shares outstanding, vested and unvested for the periods ended as follows (shares in thousands):

	June 30,	September 30,
	2023	2022
Vested and exercisable (a)	1,616	2,117
Unvested (b)	625	275
Options outstanding	2,241	2,392

(a) The weighted average exercise price of vested and exercisable shares was $6.45 and $5.86 at June 30, 2023 and September 30, 2022, respectively. Aggregate intrinsic value was approximately $6.5 million and $13.6 million at June 30, 2023 and September 30, 2022, respectively. The weighted average contractual term remaining was 4.6 years and 4.9 years at June 30, 2023 and September 30, 2022, respectively.

(b) Certain awards vest upon satisfaction of certain performance criteria.

Summary of Performance Vesting Critera

				Volatility
				50%
				Calculated
Grant Date	Performance Vesting Base	Performance Vesting Criteria	(Years)	Fair Value
January 27, 2023	Revenue	Revenue increase at the end of the performance period as compared to the year ended September 30, 2022	3	$	3.51
January 27, 2023	Stock price	Stock price is at least $33.21 per share average for the 30 days prior to the end of the performance period	3	$	2.92
Notes:
Results based on 100,000 simulations

(b) Equity grants of RSUs were made in accordance with DLH compensation policy for non-employee directors and a total of 50,367 and 53,510 restricted stock units were issued and outstanding at June 30, 2023 and 2022, respectively. These grants have service-based vesting criteria and vest at the end of this fiscal year.

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

								Volatility
								50%
					Vesting		Expected
	Strike		Stock		Threshold		Term	Calculated
Grant Date	Price		Price		Price		(Years)	Fair Value
January 26, 2023	$	11.66	$	11.66	$	15.00	10	$	7.41
Notes:
Results based on 100,000 simulations

XML

Earnings Per Share (Tables)

9 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of Diluted Earnings per Share

Earnings per share information is presented in the table below for the three and nine months ended June 30, 2023 and 2022 as follows (in thousands except for per share amounts):

	(In thousands)
	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Numerator:
Net income	$	1,738	$	4,864	$	4,090	$	19,846
Denominator:
Denominator for basic net income per share - weighted-average outstanding shares	13,854		12,812		13,638		12,779
Effect of dilutive securities:
Stock options and restricted stock	685		1,423		783		1,426
Denominator for diluted net income per share - weighted-average outstanding shares	14,539		14,235		14,421		14,205
Net income per share - basic	$	0.13	$	0.38	$	0.30	$	1.55
Net income per share - diluted	$	0.12	$	0.34	$	0.28	$	1.40

XML

Commitment and Contingencies (Tables)

9 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Contractual Obligations

Contractual obligations as of June 30, 2023 are as follows (in thousands):

			Payments Due Per Fiscal Year
			(Remaining)
	Total		2023		2024		2025		2026		2027		Thereafter
Debt obligations	$	195,760	$	3,563	$	14,250	$	19,000	$	19,000	$	23,750	$	116,197
Facility operating leases	24,636		1,148		4,561		3,928		3,700		2,627		8,672
Equipment operating leases	67		17		50		—		—		—		—
Total contractual obligations	$	220,463	$	4,728	$	18,861	$	22,928	$	22,700	$	26,377	$	124,869

XML

Significant Accounting Policies (Details)	9 Months Ended
	Jun. 30, 2023 USD ($) shares
Acquired Indefinite-lived Intangible Assets [Line Items]
Estimated useful live of intangible assets	10 years
Cash, FDIC insured amount | $	$ 250,000
Preferred shares authorized (in shares) | shares	5,000,000
Employee Stock Option
Acquired Indefinite-lived Intangible Assets [Line Items]
Expiration term of share-based compensation plan	10 years
Minimum
Acquired Indefinite-lived Intangible Assets [Line Items]
Estimated useful of long-lived assets	3 years
Maximum
Acquired Indefinite-lived Intangible Assets [Line Items]
Estimated useful of long-lived assets	7 years

XML

Business Combination - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Dec. 08, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Business Acquisition [Line Items]
Proceeds from debt obligations				$ 168,000	$ 13,500
Issuance and fair value adjustment of common stock in business combination (in shares)				527,000
Issuance and fair value adjustment of common stock in business combination				$ 6,539
Revenue		$ 102,241	$ 66,440	274,385	327,940
Income from operations		7,107	$ 7,114	16,920	$ 28,588
Grove Resource Solutions, LLC
Business Acquisition [Line Items]
Percentage of equity interest acquired	100.00%
Preliminary purchase price	$ 188,000
Proceeds from debt obligations	181,500
Issuance and fair value adjustment of common stock in business combination	6,500
Preliminary purchase price for GRSi	187,997
Escrow funds	$ 4,300
Revenue		34,400		(73,900)
Income from operations		$ (2,600)		$ (4,100)
Grove Resource Solutions, LLC | Common Stock
Business Acquisition [Line Items]
Issuance and fair value adjustment of common stock in business combination (in shares)	500,000

XML

Business Combinations - Schedule of Assets and Liabilities Purchase Price Allocation (Details) - Grove Resource Solutions, LLC - USD ($) $ in Thousands		9 Months Ended
	Dec. 08, 2022	Jun. 30, 2023
Business Acquisition, Contingent Consideration [Line Items]
Preliminary purchase price for GRSi	$ 187,997
Cash	747
Accounts receivable	25,468
Other current assets	1,354
Accounts payable and accrued expenses	2,449
Payroll liabilities	7,826
Other current liabilities	325
Equipment and improvements, net	463
Other long-term assets and liabilities	781
Intangible assets	98,688
Total identifiable net assets acquired	115,339
Goodwill	$ 72,658	$ 72,658

XML

Business Combinations - Pro Forma Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Business Acquisition [Line Items]
Basic (in shares)		12,812		12,779
Grove Resource Solutions, LLC
Business Acquisition [Line Items]
Revenue		$ 94,326	$ 301,481	$ 407,795
Net income (loss)		$ 4,603	$ 4,683	$ 15,455
Basic (in shares)	13,854	12,812	13,638	12,779
Diluted (in shares)	14,539	14,235	14,421	14,205
Basic earnings per share (loss) (in dollars per share)		$ 0.36	$ 0.34	$ 1.21
Diluted earnings per share (loss) (in dollars per share)		$ 0.32	$ 0.32	$ 1.09

XML

Revenue Recognition - Contract Balances (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Contract assets	$ 19,300	$ 7,682

XML

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Total	$ 102,241	$ 66,440	$ 274,385	$ 327,940
Prime Contractor
Disaggregation of Revenue [Line Items]
Total	97,885	58,743	259,692	304,862
Subcontractor
Disaggregation of Revenue [Line Items]
Total	4,356	7,697	14,693	23,078
Time and Materials
Disaggregation of Revenue [Line Items]
Total	51,572	44,672	154,366	263,072
Cost Reimbursable
Disaggregation of Revenue [Line Items]
Total	29,110	11,979	58,951	34,364
Firm Fixed Price
Disaggregation of Revenue [Line Items]
Total	21,559	9,789	61,068	30,504
Department of Veterans Affairs
Disaggregation of Revenue [Line Items]
Total	35,898	33,344	104,489	92,270
Department of Health and Human Services
Disaggregation of Revenue [Line Items]
Total	44,536	27,741	115,528	78,452
Department of Defense
Disaggregation of Revenue [Line Items]
Total	21,003	8,272	50,802	25,227
Department of Homeland Security
Disaggregation of Revenue [Line Items]
Total	256	(4,908)	639	126,397
Other
Disaggregation of Revenue [Line Items]
Total	$ 548	$ 1,991	$ 2,927	$ 5,594

XML

Leases - Summary of Lease Balances in Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Leases [Abstract]
Operating lease right-of-use assets	$ 17,911	$ 16,851	$ 16,851
Operating lease liabilities - current	3,478	2,235	2,235
Operating lease liabilities - long-term	16,485	$ 16,461	16,461
Total operating lease liabilities	$ 19,963		$ 18,696

XML

Leases - Narrative (Details)	9 Months Ended
	Jun. 30, 2023 sublease_option sublease
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of facilities subleased | sublease	1
Sublease term	5 years
Sublease number of additional extension options | sublease_option	2
Sublease extension option period	1 year
Weighted-average remaining lease term	6 years 3 months 18 days
Weighted-average discount rate	6.40%
Minimum | Facilities and Equipment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease term (in years)	1 year
Maximum | Facilities and Equipment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease term (in years)	7 years 10 months 24 days

XML

Leases - Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Operating	$ 1,097	$ 869	$ 2,921	$ 2,684
Short-term	83	33	225	85
Variable	47	44	63	89
Sublease income (a)	(71)	(69)	(214)	(188)
Total lease costs	$ 1,156	$ 877	$ 2,995	$ 2,670

XML

Leases - Company's Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Leases [Abstract]
2023 (remaining)	$ 1,165
2024	4,611
2025	3,928
2026	3,700
2027	2,627
Thereafter	8,672
Total future lease payments	24,703
Less: imputed interest	(4,740)
Total operating lease liabilities	19,963		$ 18,696
Less: current portion of operating lease liabilities	(3,478)	$ (2,235)	(2,235)
Long-term operating lease liabilities	$ 16,485	$ 16,461	$ 16,461

XML

Leases - Other Information Related to Leases (Details) - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 3,317	$ 2,566
Lease liabilities arising from obtaining right-of-use assets	$ 2,052	$ 0

XML

Supporting Financial Information - Accounts Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Billed receivables	$ 48,582	$ 32,814
Contract assets	19,300	7,682
Less: Allowance for doubtful accounts	0	0
Accounts Receivable, before Allowance for Credit Loss, Current	$ 67,882	$ 40,496

XML

Supporting Financial Information - Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid insurance and benefits	$ 1,316		$ 737
Other receivables	1,694		1,196
Prepaid licenses and other expenses	1,072		945
Other current assets	$ 4,082	$ 2,878	$ 2,878

XML

Supporting Financial Information - Equipment and Improvements, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Furniture and equipment	$ 877		$ 877			$ 893
Computer equipment	5,328		5,328			2,316
Computer software	1,733		1,733			4,407
Leasehold improvements	1,878		1,878			1,614
Total equipment and improvements	9,816		9,816			9,230
Less: accumulated depreciation and amortization	(8,126)		(8,126)			(7,526)
Equipment and improvements, net	1,690		1,690		$ 1,704	$ 1,704
Depreciation expense	$ 200	$ 200	$ 600	$ 800

XML

Supporting Financial Information - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation	$ 0.2	$ 0.2	$ 0.6	$ 0.8
Amortization expense of intangible assets	$ 4.1	$ 1.6	$ 10.7	$ 4.9

XML

Supporting Financial Information - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 164,542		$ 164,542		$ 65,854
Total accumulated amortization	(35,651)		(35,651)		(24,970)
Intangible assets, net	128,891		128,891		40,884
Amortization expense of intangible assets	4,100	$ 1,600	10,700	$ 4,900
Customer contracts and related customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	113,622		113,622		47,044
Total accumulated amortization	(27,087)		(27,087)		(19,731)
Covenants not to compete
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	637		637		522
Total accumulated amortization	(362)		(362)		(316)
Trade name
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	13,034		13,034		3,051
Total accumulated amortization	(1,859)		(1,859)		(1,048)
Backlog
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	37,249		37,249		15,237
Total accumulated amortization	$ (6,343)		$ (6,343)		$ (3,875)

XML

Supporting Financial Information - Goodwill (Details) $ in Thousands	9 Months Ended
	Jun. 30, 2023 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Beginning Balance	$ 65,643
Ending Balance	$ 138,301

XML

Supporting Financial Information - Estimated Future Amortization Expense of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2023 (remaining)	$ 4,096
2024	16,386
2025	16,385
2026	15,652
2027	14,624
Thereafter	61,748
Intangible assets, net	$ 128,891	$ 40,884

XML

Supporting Financial Information - Accounts Payable, Accrued Expense and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts payable	$ 15,559		$ 11,886
Accrued benefits (a)	4,073		3,857
Accrued bonus and incentive compensation	3,147		3,625
Accrued workers' compensation insurance	2,749		4,880
Other accrued expenses	74		2,614
Accounts payable and accrued liabilities	$ 25,602	$ 26,862	$ 26,862

XML

Supporting Financial Information - Debt Obligations (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Debt Instrument [Line Items]
Less: unamortized deferred financing costs	$ (7,665)		$ (1,584)
Long-term portion of debt obligations, net of deferred financing costs	188,095		20,416
Less: current portion of debt obligations, net of deferred financing costs	(28,716)	$ 0
Long-term portion of debt obligations, net of deferred financing costs	159,379	$ 20,416	20,416
Secured debt, current	14,300
Line of credit, current	16,400
Debt instrument, unamortized discount (premium) and debt issuance costs, net	2,000
Secured Debt
Debt Instrument [Line Items]
Long-term debt	179,312		22,000
Less: current portion of debt obligations, net of deferred financing costs	(28,716)		0
Secured Revolving Line of Credit
Debt Instrument [Line Items]
Long-term debt	$ 16,448		$ 0

XML

Supporting Financial Information - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest Expense	$ 4,282	$ 334	$ 9,972	$ 1,242
Amortization of deferred financing costs charged to interest expense	635	178	1,540	497
Interest expense	$ 4,917	$ 512	$ 11,512	$ 1,739

XML

Credit Facilities - Summary of Loan Facility (Details) - Secured Debt - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Line of Credit Facility [Line Items]
Long-term debt	$ 179,312	$ 22,000
Term Loans
Line of Credit Facility [Line Items]
Long-term debt	16,400	0
Revolving Line of Credit
Line of Credit Facility [Line Items]
Long-term debt	$ 179,300	$ 22,000
Revolving Line of Credit | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Interest rate spread		5.20%

XML

Credit Facilities - Narrative (Details)	3 Months Ended	9 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Line of Credit Facility [Line Items]
Debt amortization fiscal year 2021	$ 14,250,000	$ 14,250,000
Debt amortization fiscal year 2022	19,000,000	19,000,000
Debt amortization fiscal year 2023	19,000,000	19,000,000
Debt amortization fiscal year 2024	23,750,000	23,750,000
Interest Rate Swap
Line of Credit Facility [Line Items]
Derivative notional amount	112,200,000	112,200,000
Interest expense increase (less than)		600,000
Interest Rate Swap One
Line of Credit Facility [Line Items]
Derivative notional amount	$ 16,200,000	$ 16,200,000
Derivative fixed interest rate	1.61%	1.61%
Interest Rate Swap Two
Line of Credit Facility [Line Items]
Derivative notional amount	$ 96,000,000	$ 96,000,000
Derivative fixed interest rate	4.10%	4.10%
Secured Debt
Line of Credit Facility [Line Items]
Long-term debt	$ 179,312,000	$ 179,312,000	$ 22,000,000
Secured Debt | Term Loans
Line of Credit Facility [Line Items]
Fixed charge coverage ratio		1.25
Debt amortization fiscal year 2021	14,300,000	$ 14,300,000
Debt amortization fiscal year 2022	14,300,000	14,300,000
Debt amortization fiscal year 2023	19,000,000	19,000,000
Debt amortization fiscal year 2024	19,000,000	19,000,000
Debt amortization fiscal year 2025	23,800,000	23,800,000
Voluntary principal amortization of term debt	3,600,000
Long-term debt	16,400,000	$ 16,400,000	0
Secured Debt | Term Loans | Excess Cash Flows Greater Than Or Equal to 2.50
Line of Credit Facility [Line Items]
Percentage of excess cash flow for each year of funded indebtedness to EBDTA		75.00%
Ratio of funded indebtedness to adjusted EBDTA, actual		2.50
Secured Debt | Term Loans | Excess Cash Flows Less Than 2.50
Line of Credit Facility [Line Items]
Percentage of excess cash flow for each year of funded indebtedness to EBDTA		50.00%
Secured Debt | Term Loans | Excess Cash Flows Equal to 1.50
Line of Credit Facility [Line Items]
Ratio of funded indebtedness to adjusted EBDTA, actual		1.5
Secured Debt | Term Loans | Excess Cash Flows Less Than 1.50
Line of Credit Facility [Line Items]
Percentage of excess cash flow for each year of funded indebtedness to EBDTA		0.00%
Ratio of funded indebtedness to adjusted EBDTA, actual		1.5
Secured Debt | Term Loans | Maximum
Line of Credit Facility [Line Items]
Ratio of funded indebtedness to EBITDA through maturity		4.50
Secured Debt | Term Loans | Maximum | Excess Cash Flows Less Than 2.50
Line of Credit Facility [Line Items]
Ratio of funded indebtedness to adjusted EBDTA, actual		2.50
Secured Debt | Term Loans | Minimum
Line of Credit Facility [Line Items]
Ratio of funded indebtedness to EBITDA through maturity		2.00
Secured Debt | Revolving Line of Credit
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing capacity	70,000,000	$ 70,000,000
Line of credit, unused borrowing capacity	32,900,000	32,900,000
Long-term debt	$ 179,300,000	$ 179,300,000	22,000,000.0
Secured Debt | Letter of Credit
Line of Credit Facility [Line Items]
Line of credit, current borrowing capacity			$ 10,000,000

XML

Stock-based Compensation and Equity Grants - Narrative (Details) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2023 USD ($) shares	Jun. 30, 2023 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercises in period, intrinsic value | $	$ 0.2	$ 3.4
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards authorized for issuance (in shares)	0	0
Expiration term of share-based compensation plan		10 years
Number of shares available for grant (in shares)	900,000	900,000

XML

Stock-based Compensation and Equity Grants - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Expense related to employee stock-based compensation		$ 481		$ 1,466
Expense related to director restricted stock units	$ 179	162	$ 539	486
Total unrecognized expense	7,513	5,660	$ 7,513	5,660
Volatility			50.00%
Additional Paid-In Capital
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Expense related to employee stock-based compensation		481		1,466
Expense related to director restricted stock units	179	162	$ 539	$ 486
Restricted Stock Units
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of restricted stock units granted (in shares)			337,578	161,485
Expected term (years)			3 years
DLH employees
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total unrecognized expense	7,358	5,498	$ 7,358	$ 5,498
Weighted average share based compensation expense recognition period			4 years 1 month 6 days
Non-employee directors
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total unrecognized expense	$ 155	162	$ 155	$ 162
Non-employee directors | Restricted Stock Units
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of restricted stock units granted (in shares)			50,367	53,510
NEO | Restricted Stock Units
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of restricted stock units granted (in shares)			197,174
Volatility	50.00%
NEO | Performance Based Restricted Stock Units (RSUs)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of restricted stock units granted (in shares)			141,892
NEO | Service Based Restricted Stock Units (RSUs)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of restricted stock units granted (in shares)			55,282
Selling, General and Administrative Expenses
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock option expense	$ 668	$ 643	$ 2,020	$ 1,952

XML

Stock-based Compensation and Equity Grants - Performance Based Awards (Details)	9 Months Ended
	Jun. 30, 2023 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	50.00%
Stock Price Per Share, Minimum Average Price	$ 33.21
Performance Based Restricted Stock Awards, Revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	3 years
Calculated fair value (in dollars per share)	$ 3.51
Performance Based Restricted Stock Awards, Stock Price
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	3 years
Calculated fair value (in dollars per share)	$ 2.92

XML

Stock-based Compensation and Equity Grants - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Jan. 26, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility				50.00%
Number of Shares
Options outstanding, September 30, 2021 (in shares)			2,392,000	2,392,000
Granted (in shares)				400,000
Exercised (in shares)				(393,000)
Cancelled (in shares)				(158,000)
Options outstanding, December 31, 2021 (in shares)		2,241,000		2,241,000
Weighted Average Exercise Price
Options outstanding, September 30, 2021 (in dollars per share)			$ 7.05	$ 7.05
Granted (in dollars per share)				11.66
Exercised (in dollars per share)				3.42
Cancelled (in dollars per share)				9.07
Options outstanding, December 31, 2021 (in dollars per share)		$ 8.36		$ 8.36
Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term			5 years 4 months 24 days	5 years 11 months 1 day
Aggregate Intrinsic Value
Options outstanding at September 30, 2021			$ 13,566	$ 13,566
Options outstanding at December 31, 2021		$ 6,499		$ 6,499
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)				3 years
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	10 years			10 years
Stock price threshold term				10 days
NEO | Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility		50.00%

XML

Stock-based Compensation and Equity Grants - Stock Options Fair Value Assumptions (Details) - $ / shares		9 Months Ended
	Jan. 26, 2023	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility		50.00%
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Strike price (in dollars per share)	$ 11.66
Stock price (in dollars per share)	11.66
Threshold vesting price (in dollars per share)	$ 15.00
Expected term (years)	10 years	10 years
Calculated fair value (in dollars per share)	$ 7.41

XML

Stock-based Compensation and Equity Grants - Stock Options Outstanding, Vested and Unvested (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended	9 Months Ended
	Dec. 31, 2022	Jun. 30, 2023	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Vested and exercisable (in shares)		1,616	2,117
Unvested (in shares)		625	275
Option outstanding (in shares)		2,241	2,392
Weighted average exercise price (in dollars per share)		$ 6.45	$ 5.86
Aggregate intrinsic value		$ 6.5	$ 13.6
Weighted average remaining term	4 years 10 months 24 days	4 years 7 months 6 days

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Numerator:
Net income	$ 1,738	$ 4,864	$ 4,090	$ 19,846
Denominator:
Denominator for basic net income (loss) per share - weighted-average outstanding shares (in shares)		12,812		12,779
Effect of dilutive securities:
Stock options and restricted stock (in shares)	685	1,423	783	1,426
Net income per share - basic (in dollars per share)	$ 0.13	$ 0.38	$ 0.30	$ 1.55
Net income per share - diluted (in dollars per share)	$ 0.12	$ 0.34	$ 0.28	$ 1.40

XML

Commitments and Contingencies - Contractual Obligations (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Debt obligations
2022 (remaining)	$ 3,563
2024	14,250
2025	19,000
2026	19,000
2027	23,750
Thereafter	116,197
Operating Leases
Total future lease payments	24,703
2023 (remaining)	1,165
2024	4,611
2025	3,928
2026	3,700
2027	2,627
Thereafter	8,672
Total Contractual Obligations
Total Obligations	220,463
2022 (remaining)	4,728
2024	18,861
2025	22,928
2026	22,700
2027	26,377
Thereafter	124,869
Debt Obligation
Total Contractual Obligations
Total Obligations	195,760
Facility operating leases
Operating Leases
2023 (remaining)	1,148
2024	4,561
2025	3,928
2026	3,700
2027	2,627
Thereafter	8,672
Total Contractual Obligations
Total Obligations	24,636
Equipment operating leases
Operating Leases
2023 (remaining)	17
2024	50
2025	0
2026	0
2027	0
Thereafter	0
Total Contractual Obligations
Total Obligations	$ 67

XML

Commitment and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Accrued workers' compensation insurance	$ 2,749	$ 4,880